<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="chapter-article"><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><?noissn?><front><journal-meta><journal-id journal-id-type="publisher-id">978-94-007-3926-0</journal-id><journal-id journal-id-type="doi">10.1007/978-94-007-3926-0</journal-id><journal-id journal-id-type="nlm-ta">Dietary Phytochemicals and Microbes</journal-id><journal-title-group><journal-title>Dietary Phytochemicals and Microbes</journal-title></journal-title-group><isbn publication-format="print">978-94-007-3925-3</isbn><isbn publication-format="electronic">978-94-007-3926-0</isbn></journal-meta><article-meta><article-id pub-id-type="pmcid">7120890</article-id><article-id pub-id-type="publisher-id">3</article-id><article-id pub-id-type="doi">10.1007/978-94-007-3926-0_3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Antiviral Properties of Phytochemicals</article-title></title-group><contrib-group content-type="book editors"><contrib contrib-type="editor"><name><surname>Patra</surname><given-names>Amlan K.</given-names></name><address><email>patra_amlan@yahoo.com</email></address><xref ref-type="aff" rid="AffID1"/></contrib><aff id="AffID1"><institution-wrap><institution-id institution-id-type="GRID">grid.419478.7</institution-id><institution-id institution-id-type="ISNI">000000041768519X</institution-id><institution>of Animal and Fishery Sciences, Department of Animal Nutrition, </institution><institution>West Bengal University, </institution></institution-wrap>Kshudiram Bose Sarani 37, Belgachia, Kolkata, 700 037 India </aff></contrib-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Liu</surname><given-names>Ai-Lin</given-names></name><address><email>liuailin@imm.ac.cn</email></address><xref ref-type="aff" rid="Aff1_3"/></contrib><contrib contrib-type="author"><name><surname>Du</surname><given-names>Guan-Hua</given-names></name><address><email>dugh@imm.ac.cn</email></address><xref ref-type="aff" rid="Aff1_3"/></contrib><aff id="Aff1_3"><institution-wrap><institution-id institution-id-type="GRID">grid.413106.1</institution-id><institution-id institution-id-type="ISNI">0000000098896335</institution-id><institution>Beijing Key Laboratory of Drug Target Research and Drug Screening, Institute of Materia Medica, </institution><institution>Chinese Academy of Medical Sciences and Peking Union Medical College, </institution></institution-wrap>1 Xian Nong Tan Street, Beijing, 100050 China </aff></contrib-group><pub-date pub-type="epub"><day>18</day><month>2</month><year>2012</year></pub-date><fpage>93</fpage><lpage>126</lpage><permissions><copyright-statement>&#x000a9; Springer Science+Business Media Dordrecht 2012</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><abstract id="Abs1_3"><p>In recent years, significant progress has been achieved for the development of novel anti-viral drugs. These newly developed drugs belong to three groups of compounds, nucleoside analogues, thymidine kinase-dependent nucleotide analogues and specific viral enzyme inhibitors. It has been found that the natural products, like plant-derived compounds (phytochemicals) as well as traditional medicines, like traditional Chinese medicines (TCM), Ayurvedic medicines and so on, are the important sources for potential and novel anti-viral drugs. In this chapter, the history of natural products as antiviral drugs, the approaches to discover potential lead compounds, and the anti-viral properties of phytochemicals with different action mechanisms are discussed. The key conclusion is that natural products are most important sources for novel anti-viral drugs.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Phytochemicals</kwd><kwd>Polysaccharides</kwd><kwd>Flavonoids</kwd><kwd>Organic acids</kwd><kwd>Alkaloids</kwd><kwd>Saponins</kwd><kwd>Essential oils</kwd><kwd>Stilbenes</kwd><kwd>Antiviral activity assay</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media Dordrecht 2012</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1_3" sec-type="introduction"><title>Introduction</title><p>A virus is a small, infectious agent, which contains little more than bundles of gene strands of gene strands of either RNA or DNA, and may be surrounded bya shell of protein. Unlike bacterial cells, which are free-living entities, viruses utilize the host cell environment to propagate new viruses. The newly made viruses then leave the host cell, sometimes killing it in the process, and proceed to infect other cells within the host. Virus infection can cause a mild illness as a cold or a deadly illness as the bloody African fever. The viruses that cause Lassa fever and Ebola fever and the retrovirus that causes acquired immunodeficiency syndrome (AIDS) are examples spreading easily, threatening people&#x02019;s life and health sometimes swiftly, and for which there is no cure or vaccine (Jassim and Naji <xref ref-type="bibr" rid="CR74_3">2003</xref>). Viral infection has become one of the main causes of morbidity and mortality worldwide (Golean et al. <xref ref-type="bibr" rid="CR01_3">2009</xref>).</p><p>Since viruses have plenty of invasion strategies. Each strain of virus has its unique configuration of surface molecules, which work like keys in locks, enabling viruses enter into hosts by accurately fitting the molecules on their surfaces of target cells (Jassim and Naji <xref ref-type="bibr" rid="CR74_3">2003</xref>). Since viruses and hosts are intimately connected, the designing of effective anti-virals that will inhibit the viral enzymes or its replication without affecting the host cells has proved to be difficult (Golean et al. <xref ref-type="bibr" rid="CR01_3">2009</xref>; Chattopadhyay et al. <xref ref-type="bibr" rid="CR24_3">1999</xref>). The public health measures and prophylactic vaccines are still the important means, by which society controls the spread of viral infections.</p><p>With the advances in molecular biology and reverse genetics in the past two decades, many viruses have been known to have unique features in their structures or in their replication cycles, which are their potential targets. Since viral enzymes are crucial for disease progression and virus replication, inhibitors against viral enzymes have been the most desirable strategies. Most of the well-studied inhibitors against HIV, herpes simplex virus (HSV) or the influenza viruses target the host cell binding (T-20, betulinic acid, etc.), uncoating of capsid (amantadine derivatives, pleconaril), replication (reverse transcriptase inhibitors like zidovudine or abacavir, nevirapine, etc.), integrase inhibitors, DNA or RNA polymerase inhibitors (acyclovir, cidofovir, ribavirin, etc.), proteinase involved in viral polyprotein precursors and assembly/maturation inhibitors (indinavir, ritonavir and rimantadine, etc.). Based on this strategy, numerous compounds have been tested on different viruses in the past decades, but there are still less than 40 licensed anti-virals in the market (Chattopadhyay et al. <xref ref-type="bibr" rid="CR27_3">2009</xref>).</p><p>The development of viral resistance towards current antiviral agents enhances the need for new effective compounds against viral infections. Some new anti-viral compounds are currently undergoing either preclinical or clinical evaluation, and perspectives for finding new interesting antiviral drugs are promising (Chattopadhyay et al. <xref ref-type="bibr" rid="CR27_3">2009</xref>). Among these antiviral substances are several natural compounds isolated from plants used in traditional medicines.</p><p>According to statistics, natural products have become one of the main resources for new drug research and development in the past two decades, especially for the treatment of infectious diseases. Approximately 44% of the antiviral drugs approved between 1981 and 2006 were natural products, semi-synthetic natural product analogues or synthetic compounds based on natural-product pharmacophores (Newman and Cragg <xref ref-type="bibr" rid="CR129_3">2007</xref>). Drug screening of plant extracts has led to the evaluation of their <italic>in vitro</italic> antiviral activities (Jassim and Naji <xref ref-type="bibr" rid="CR74_3">2003</xref>; Mukhtar et al. <xref ref-type="bibr" rid="CR128_3">2008</xref>). In addition, the application of new technologies and methods, such as high throughput screening (HTS) and molecular biology, has greatly increased the probability of finding valuable new bioactive plant extract(s) or compound(s) (Li and Vederas <xref ref-type="bibr" rid="CR98_3">2009</xref>).</p><p>In this chapter, (1) the history of natural products as antiviral drugs, (2) the main <italic>in vitro</italic> models used to discover and evaluate potential &#x0201c;lead&#x0201d; compounds as &#x0201c;antiviral substances&#x0201d;, and (3) the anti-viral properties of phytochemicals with special action mechanisms have been reviewed.</p></sec><sec id="Sec2_3"><title>History of Natural Products as Antiviral Drugs</title><p>The history of medicinal plants can date back to the origin of human civilization on earth (Mukhtar et al. <xref ref-type="bibr" rid="CR128_3">2008</xref>). In the early times, natural products were directly used for the treatment of diseases, including viral infection diseases. Natural products have made great contributions to human health, many active constituents from natural pro&#x000ad;ducts have been determined and their mechanisms of action have been elucidated.</p><p>The inhibitory effects of medicinal plants extracts on the replication of several viruses were reported in the past six decades. In 1952, 288 plants for anti-influenza activity were evaluated by the Boots drug company (Nottingham, England); 12 out of these plants were found to be effective against influenza viruses in embryonated eggs (Chantrill et al. <xref ref-type="bibr" rid="CR23_3">1952</xref>). In the 1970s, the antiviral activities of extracts from grape, apple, strawberry and other fruit juices against HSV, poliovirus type 1, coxsackievirus B5 and echovirus 7 were reported (Konowalchuk and Speirs <xref ref-type="bibr" rid="CR86_3">1976</xref>, <xref ref-type="bibr" rid="CR87_3">1978a</xref>, <xref ref-type="bibr" rid="CR88_3">b</xref>). In 1995, 100 British Colombian medicinal plants were also reported to have antiviral activities, 12 out of which showed significant antiviral effect against corona viruses, respiratory syncytial virus (RSV), para-influenza virus type 3 (PI3), herpesvirus type 1 (HSV-1) and retavirus (McCutcheon et al. <xref ref-type="bibr" rid="CR122_3">1995</xref>). In 1998, more than 800 common Chinese herbal medicines were detected for antiviral activities against HIV and more than 100 plants exhibited anti-HIV activities (Lou <xref ref-type="bibr" rid="CR115_3">1998</xref>). In 2005, more than 200 Chinese herbal medicines were screened for antiviral activities against Severe Acute Respiratory Syndrome associated coronavirus (SARS-CoV), 4 out of which showed potent antiviral activities (Li et al. <xref ref-type="bibr" rid="CR104_3">2005a</xref>).</p><p>In addition, herpes simplex virus type 2 (HSV-2) (Debiaggi et al. <xref ref-type="bibr" rid="CR41_3">1988</xref>), HIV (Asres and Bucar <xref ref-type="bibr" rid="CR11_3">2005</xref>; Vermani and Garg <xref ref-type="bibr" rid="CR175_3">2002</xref>), hepatitis B virus (HBV) (Huang et al. <xref ref-type="bibr" rid="CR67_3">2003</xref>, <xref ref-type="bibr" rid="CR68_3">2006</xref>; Kwon et al. <xref ref-type="bibr" rid="CR95_3">2005</xref>), dengue virus type-2 (DEN-2) (Parida et al. <xref ref-type="bibr" rid="CR136_3">2002</xref>; Reis et al. <xref ref-type="bibr" rid="CR143_3">2008</xref>) and emerging viral infections associated with poxvirus and severe acute respiratory syndrome (SARS) virus (Kotwal et al. <xref ref-type="bibr" rid="CR89_3">2005</xref>) were strongly inhibited by various plants extracts. Most of these studies utilized either water soluble or alcoholic extracts of medicinal plants, and limited efforts have been directed toward the identification of active natural ingredients exhibiting antiviral effects. Some typical examples of traditional plant medicines and their antiviral activities are shown in Table <xref rid="Tab1_3" ref-type="table">3.1</xref>.<table-wrap id="Tab1_3"><label>Table 3.1</label><caption><p>Partial viruses inhibited by medicinal plants</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Virus</th><th>Medicinal plant used</th><th>Antiviral effect</th><th>Reference</th></tr></thead><tbody><tr><td rowspan="2">Hepatitis C virus (HCV)</td><td>
<italic>Acacia nilotica</italic> L.</td><td>Exhibited significant activity against HCV <italic>in vitro</italic>
</td><td>Rehman et al. (<xref ref-type="bibr" rid="CR142_3">2011</xref>)</td></tr><tr><td>
<italic>Solanum nigrum</italic> L.</td><td>Displayed potential antiviral activity against HCV</td><td>Javed et al. (<xref ref-type="bibr" rid="CR75_3">2011</xref>)</td></tr><tr><td rowspan="3">Hepatitis B virus (HBV)</td><td>
<italic>Ophioglossum pedunculosum</italic> Desv.</td><td>Exhibit modest activity of blocking HBsAg secretion <italic>in vitro</italic>
</td><td>Wan et al. (<xref ref-type="bibr" rid="CR178_3">2011</xref>)</td></tr><tr><td>
<italic>Boehmeria nivea</italic> L.</td><td>Reduced HBV production in an <italic>in vitro</italic> and <italic>in vivo</italic> model</td><td>Huang et al. (<xref ref-type="bibr" rid="CR68_3">2006</xref>)</td></tr><tr><td>
<italic>Polygonum cuspidatum</italic> Sieb. and Zucc.</td><td>Inhibited hepatitis B virus in a stable HBV-producing cell line</td><td>Chang et al. (<xref ref-type="bibr" rid="CR22_3">2005</xref>)</td></tr><tr><td rowspan="2">Herpes simplex virus (HSV)</td><td>
<italic>Carissa edulis</italic> Vahl.</td><td>Exhibited strong anti-HSV 1 and 2 activities both <italic>in vitro</italic> and <italic>in vivo</italic>
</td><td>Tolo et al. (<xref ref-type="bibr" rid="CR173_3">2006</xref>)</td></tr><tr><td>
<italic>Geranium sanguineum</italic> L.</td><td>Significantly inhibited the replication of HSV-1 and HSV-2 <italic>in vitro</italic>
</td><td>Serkedjieva and Ivancheva (<xref ref-type="bibr" rid="CR157_3">1999</xref>)</td></tr><tr><td rowspan="2">Influenza virus</td><td>
<italic>Geranium sanguineum</italic> L.</td><td>Reduced the infectivity of various influenza virus strains <italic>in vitro</italic> and <italic>in vivo</italic>
</td><td>Pantev et al. (<xref ref-type="bibr" rid="CR135_3">2006</xref>) and Serkedjieva (<xref ref-type="bibr" rid="CR155_3">1997</xref>)</td></tr><tr><td>Elderberry</td><td>Showed an efficient, safe and cost-effective treatment for influenza <italic>in vitro</italic>
</td><td>Zakay-Rones et al. (<xref ref-type="bibr" rid="CR194_3">2004</xref>)</td></tr><tr><td>Poliovirus</td><td>
<italic>Guazuma ulmifolia</italic> Lam.</td><td>Inhibited poliovirus replication, as well as, blocked the synthesis of viral antigens in infected cell cultures</td><td>Felipe et al. (<xref ref-type="bibr" rid="CR51_3">2006</xref>)</td></tr><tr><td>Viral haemorrhagic septicaemia virus (VHSV)</td><td>
<italic>Olea europaea</italic> L.</td><td>Inhibited viral replication <italic>in vitro</italic>
</td><td>Micol et al. (<xref ref-type="bibr" rid="CR126_3">2005</xref>)</td></tr><tr><td rowspan="2">Human immunodeficiency virus (HIV)</td><td><p>
<italic>Phyllanthus amarus</italic> Schum.</p><p>and Thonn</p></td><td>Inhibited HIV replication both <italic>in vitro</italic> and <italic>in vivo</italic>
</td><td>Notka et al. (<xref ref-type="bibr" rid="CR131_3">2004</xref>)</td></tr><tr><td>Olive leaf</td><td>Inhibited acute infection and cell-to-cell transmission of HIV-1</td><td>Lee-Huang et al. (<xref ref-type="bibr" rid="CR67_3">2003</xref>)</td></tr><tr><td>Vesicular stomatitis virus (VSV)</td><td>
<italic>Trichilia glabra</italic> L.</td><td>Inhibited VSV <italic>in vitro</italic>
</td><td>Cella et al. (<xref ref-type="bibr" rid="CR20_3">2004</xref>)</td></tr><tr><td>Human adenovirus type 1</td><td rowspan="2">Black soybean</td><td rowspan="2">Inhibited human adenovirus type 1 and coxsackievirus B1 <italic>in vitro</italic>
</td><td rowspan="2">Yamai et al. (<xref ref-type="bibr" rid="CR188_3">2003</xref>)</td></tr><tr><td>Coxsackievirus B1</td></tr><tr><td rowspan="2">Dengue virus type-2 (DENV-2)</td><td>
<italic>Azadirachta indica</italic> Juss.(Neem)</td><td>Inhibited DENV-2 both <italic>in vitro</italic> and <italic>in vivo</italic>
</td><td>Parida et al. (<xref ref-type="bibr" rid="CR136_3">2002</xref>)</td></tr><tr><td>
<italic>Uncaria tomentosa</italic> (Willd.) DC.</td><td>Displayed <italic>in vitro</italic> antiviral activity against DENV-2</td><td>Reis et al. (<xref ref-type="bibr" rid="CR143_3">2008</xref>)</td></tr><tr><td>Severe Acute Respiratory Syndrome associated coronavirus (SARS-CoV)</td><td>
<italic>Lycoris radiate, Artemisia annua</italic>
</td><td>Showed potent antiviral activities against SARS-CoV <italic>in vitro</italic>
</td><td>Li et al. (<xref ref-type="bibr" rid="CR104_3">2005a</xref>)</td></tr></tbody></table></table-wrap>
</p><p>Moreover, recent studies showed that plant extracts possess antiviral potential of against viral strains resistant to conventional antiviral agents (Serkedjieva <xref ref-type="bibr" rid="CR156_3">2003</xref>; Tolo et al. <xref ref-type="bibr" rid="CR173_3">2006</xref>), which have challenged the modern drug discovery practices. Thus, the further exploration of natural antiviral components of medicinal plants is necessary.</p><p>Although medicinal plants have been used throughout the world, however, their wide usage has been limited to China, India, Japan, Pakistan, Sri Lanka, Thailand and a number of African countries. However, developed countries are gradually accepting the usage of plant-based natural medicinal products in their healthcare systems. In England, because of the outstanding performance of TCMs on some stubborn diseases, such as skin eczema, currently the British government appears to support the research and the usage of TCMs, and therefore the international drug market for TCMs has been rapidly expanded, especially in England (Jiang <xref ref-type="bibr" rid="CR76_3">2005</xref>).</p><p>Besides, the Natural Health Product Regulations of Canada promulgated in 2004 and the performance of phase III clinical trial of Chinese medicine Danshen dripping pills in America in 2010 are also very important steps toward modernization of plant-based product usage in healthcare. These advances encourage the usage of modern technology and evidence-based scientific support toward promoting medicinal plants and the associated products (Siow et al. <xref ref-type="bibr" rid="CR164_3">2005</xref>).</p></sec><sec id="Sec3_3"><title>Common Models for Antiviral Activity Assay</title><p>The antiviral activities of natural products, including ingredients, fractions and extracts, need to be evaluated by various anti-viral models, including <italic>in vitro</italic> and <italic>in vivo</italic> models. Besides, the analysis of assay results of natural products is also very important. In the present section, the models to evaluate the <italic>in vitro</italic> anti-viral activities of potential natural products have been summarized, and the evaluation methods of several representative models have been introduced. The antiviral models include molecular level models and cellular level models (Table <xref rid="Tab2_3" ref-type="table">3.2</xref>; Chattopadhyay et al. <xref ref-type="bibr" rid="CR27_3">2009</xref>).<table-wrap id="Tab2_3"><label>Table 3.2</label><caption><p>Molecular level, and cellular level for testing anti-viral agents against common viruses</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Virus</th><th>Disease</th><th>Molecular level model</th><th>Cellular level model</th></tr></thead><tbody><tr><td>HSV</td><td>Herpes</td><td>DNA polymerase assay</td><td>Plaque assay (Vero, MRC-5, HFF, BHK, HEp-2 cell lines)</td></tr><tr><td>Influenza</td><td>Flu</td><td>NA, HA, RNA polymerase assays</td><td>Plaque assay, HA, HAI, RT-PCR (MDCK, A549 cell lines)</td></tr><tr><td>Hepatitis C virus (HCV)</td><td>Liver cirrhosis</td><td>Protease, RNA polymerase assay</td><td>RT- PCR, no cell line facility</td></tr><tr><td>HBV</td><td>Liver cirrhosis</td><td>Reverse transcriptase assay, interferons</td><td>RT- PCR (HepG2 2.2.15)</td></tr><tr><td>Entero virus</td><td>Diarrhoea</td><td/><td>RT-PCR, PAGE</td></tr><tr><td>RSV</td><td>Common cold</td><td>RNA polymerase assay</td><td>Plaque assay, MTT assay, RT-PCR Cell-ELISA, HEp-2</td></tr><tr><td>HIV</td><td>AIDS</td><td>Reverse transcriptase and integrase activity assays</td><td>Primary macrophages, HFF cells</td></tr><tr><td>Rabies virus</td><td>Hydrophoba</td><td/><td>McCoy cells</td></tr><tr><td>Polio virus</td><td>Paralysis, Aseptic meningitis</td><td>RNA polymerase assay</td><td>Plaque assay, RT-PCR (Hela cell line)</td></tr></tbody></table></table-wrap>
</p><sec id="Sec4_3"><title>Molecular Level Models</title><p>Molecular level models are usually the first step in screening a large number of substances, including compounds or extracts, for their inhibition and action mechanisms on viral enzymes or function proteins, and therefore provide useful activity information for further strategy for drug discovery, including the related molecular level models and/or cellular level models.</p><sec id="Sec5_3"><title>Reverse Transcriptase (RT) Activity Assay</title><p>RT activity can be assayed by adding lysates to a 96-well microtiter plate which has a poly (A) nucleotide chain covalently bound to the base of each well. A mix of 5&#x02032; bromodeoxyuridine triphosphate (BrdUTP) is added, and the plate is incubated at 33&#x000b0;C for 48 h (Sivapalasingam et al. <xref ref-type="bibr" rid="CR165_3">2005</xref>).</p><p>The plate is washed to terminate the reaction and a BrdU-binding antibody conjugated to alkaline phosphatase (AP) is added and incubated at 33&#x000b0;C for 90 min.</p><p>Following a second wash, the AP substrate p-nitrophenyl phosphate is added and the resulting yellow color change is measured to quantify the amount of incorporated BrdUTP. Following addition of the AP substrate each plate is read at three time points: 10 min, 2&#x02013;3 h, and 5&#x02013;6 h or overnight at 15&#x02013;24 h. The results are expressed in femtograms HIV-1 RT activity/ml plasma. The lower limit of detection is &#x0003c;1 fg/ml. Results are calculated using ExaVir Load Analyzer software that automatically determines the amount of RT activity in samples using a standard curve generated from an 11-point dilution of a known amount of recombinant HIV-1 RT. The results are also given in units of HIV-1 RNA equivalent copies/ml using a conversion factor derived from a Swedish cohort comprised mainly of subtype B virus. Assay precision is determined on duplicates of five samples, and assay reproducibility is determined on seven samples run on different days.</p></sec><sec id="Sec6_3"><title>DNA Polymerase Activity Assay</title><p>Although different DNA polymerases have distinct functions and substrate affinities, their general mechanism of action is similar. Thus, they can all be studied using the same technical principle, the primer extension assay employing radioactive tags (Lope et al. <xref ref-type="bibr" rid="CR02_3">2007</xref>).</p><p>To explore the use of fluorescent primers in assaying DNA polymerase activity with <italic>in vitro</italic> primer extension, we can use the following 40 mer oligodeoxynucleotides as templates: an oligo dT (5&#x02032; TTTTTTTTTTTTTTTTTTTTTTT GTCGTGACTGGGAAAAC) and a (dC.dA)n template (5&#x02032; CACACACACACACACACACACACGTCGTGACTGGGAAAAC), where the underlined sequences are the 17-mer M13 (&#x02212;40) universal primer sequence. Fluorescein-labeled M13 primer (0.5 &#x003bc;M; Alpha DNA, Montreal, Canada) is annealed to the two templates (0.8 &#x003bc;M each) in the presence of 50 mM Tris-HCl, pH 7.5, and 100 mM NaCl by heating to 90&#x000b0;C for 5 min, followed by cooling to 25&#x000b0;C over several hours, to obtain our substrate.</p><p>Since the Klenow fragment of DNA polymerase I is very well characterized, it is used as a model in the experiments. Maintaining the same conditions as in radioactive labeling primer experiments (Tuske et al. <xref ref-type="bibr" rid="CR03_3">2000</xref>; Lestienne et al. <xref ref-type="bibr" rid="CR04_3">2003</xref>), it could be assessed in different settings for Klenow activity. Briefly, DNA polymerase I (Klenow fragment) is incubated with a plant constituent, 5&#x02032;-fluorescein-end-labeled primer-template substrate (50 nM), 200 &#x003bc;M deoxynucleotide, 10 mM Tris-HCl, pH 5, 6, 7 or 8, 5 mM dithiothreitol, 100 &#x003bc;g/ml bovine serum albumin, 0, 10, 100 or 200 mM MgCl<sub>2</sub> and 0, 50, 100 or 200 mM NaCl. Reaction mixtures are incubated at 37&#x000b0;C for 30 min. The reaction is quenched by the addition of stop solution (10 &#x003bc;l) (80% deionized formamide, 10 mM EDTA, pH 8, 1 mg/ml xylene cyanol, and 1 mg/ml bromophenol blue) heated to 90&#x000b0;C for 2 min and placed on ice. Products are resolved on denaturing polyacrylamide sequencing gels in an automated ALF DNA sequencer (GE Healthcare). Analyses of the deoxynucleotide incorporation are carried out with Allelelinks software, version 1.0 (GE Healthcare).</p></sec><sec id="Sec7_3"><title>Neuraminidase Inhibition Assay</title><p>A standard fluorimetric assay is used to measure influenza virus NA activity. The substrate MUNANA (2&#x02032;-(methylumbelliferyl)-&#x003b1;-D-acetylneuraminic acid) is cleaved by NA to yield a fluorescent product, which can be quantified. The reaction mixture containing the test compounds/extracts and NA enzyme or a virus suspension in 32.5 mM MES buffer with 4 mM CaCl<sub>2</sub> (pH 6.5) is incubated for 40 min at 37&#x000b0;C. After incubation, the reaction is terminated by the addition of 34 mM NaOH. The fluorescence is quantified at an excitation wavelength of 360 nm and emission wavelength of 450 nm. The 50% inhibitory concentration (IC<sub>50</sub>) is defined as the concentration of NA inhibitor necessary to reduce the NA activity by 50% relative to that in a reaction mixture containing virus but no inhibitor (Liu et al. <xref ref-type="bibr" rid="CR110_3">2008a</xref>).</p></sec><sec id="Sec8_3"><title>Hemagglutination Inhibition Assay</title><p>The hemagglutination assay (HA) is a quantitation of hemagglutination protein of viruses. Some viral families have surface or envelope proteins, which are able to agglutinate (stick to) human or animal red blood cells (RBC) and bind to its N-acetylneuraminic acid. The RBC will form a type of lattice in this case. In contrast to plaque assay or LD<sub>50</sub>, HA does not give any measure of viral infectivity, because no virus replication is required in this assay. It is an easy, simple and rapid method and can be applied to large amounts of samples. The detailed conditions depend on the type of virus. Some viruses bind RBCs only at certain pH values, others at certain ionic strengths.</p><p>If the test compounds inhibit virus replication and thus viral titre, the HA value will be reduced. HA inhibition assay is employed to test the effect of the test compounds in virus adsorption to target cells. Compound solutions (25 &#x003bc;l) with twofold serial dilution with PBS are mixed with equal volume of influenza virus solution (200HAU/25 &#x003bc;l). After incubation for 30 min at room temperature, 50 &#x003bc;l of the solution is mixed with equal volume of 1% chicken erythrocyte suspension and incubated for 30 min at room temperature (Song et al. <xref ref-type="bibr" rid="CR166_3">2005</xref>).</p></sec></sec><sec id="Sec9_3"><title>Cellular Level Models</title><p>Cellular level models usually exploit the virus&#x02019;s ability to infect and replicate in specific cell lines in cell culture systems. The cell culture system provides a rapid method to grow viruses at higher titres to test the antiviral activity of compounds/extracts. It is based on the observation that virus infection and multiplication results in cytopathic effect (CPE) due to either release of virus or induction of apoptosis as a result of host immune responses. Inhibition of CPE in presence of test compound could be due to inhibition of virus replication. The assay results combined with molecular level assay results will guide the later study in animal models.</p><sec id="Sec10_3"><title>Cytotoxicity in MDCK Cells</title><p>Cell viability is determined with the MTT (3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di-phenytetrazoliumromide) method (Liu et al. <xref ref-type="bibr" rid="CR110_3">2008a</xref>). Consecutive threefold serial dilutions (100 &#x003bc;l) of compounds/extracts and reference compounds are added to cell monolayers in replicates. Blank medium is used as a control. After 3 days of incubation at 37&#x000b0;C, 12 &#x003bc;l of MTT solution (5 mg/ml in phosphate-buffered saline) is added to each well. The plate is further incubated at 37&#x000b0;C for 3 h to allow the formation of the formazan product. After removal of the medium, 100 &#x003bc;l of dimethyl sulfoxide (DMSO) is added to dissolve the formazan crystals. After 15 min, the contents of the wells are homogenized on a microplate shaker. The optical densities are then measured with a microplate spectrophotometer at a wavelength of 540 nm. The median cytotoxic concentration (CC<sub>50</sub>) is calculated as the concentration of the tested sample that reduced the number of viable cells to 50% of the untreated control. The maximal non-cytotoxic concentration (MNCC) is defined as the maximal concentration of the sample that does not exert a cytotoxic effect and resulted in more than 90% viable cells.</p></sec><sec id="Sec11_3"><title>CPE Reduction Assay</title><p>The antiviral activities of the test compounds/extracts are measured with the CPE inhibition assay (Liu et al. <xref ref-type="bibr" rid="CR111_3">2008b</xref>). Viral suspension (200 TCID<sub>50</sub>/ml, 100 &#x003bc;l) is added to each well of a 96-well plate containing a confluent cell monolayer. After incubation at 37&#x000b0;C for 2 h, the virus solution is removed, and 100 &#x003bc;l of consecutive threefold serial dilutions of the test compounds/extracts and reference compounds are added to each well, using the MNCC as the highest concentration. An infection control without samples is also included. The plates are incubated at 37&#x000b0;C in a humidified CO<sub>2</sub> atmosphere (5% CO<sub>2</sub>) for 24 h, after which the CPE is assessed. The virus-induced CPE is scored as follows: 0 &#x02009;= &#x02009;no CPE, 1 &#x02009;= &#x02009;0&#x02013;25% CPE, 2 &#x02009;= &#x02009;25&#x02013;50% CPE, 3 &#x02009;= &#x02009;50&#x02013;75% CPE, and 4 &#x02009;= &#x02009;75&#x02013;100% CPE. The reduction in virus multiplication is calculated as a percentage of the virus control (% virus control &#x02009;= &#x02009;CPE<sub>exp</sub>/CPE<sub>virus control</sub> &#x02009;&#x000d7; &#x02009;100). The IC<sub>50</sub> of the CPE with respect to the virus control is estimated using the Reed&#x02013;Muench method. The selective index (SI) is calculated as the ratio CC<sub>50</sub>/IC<sub>50</sub>.</p></sec><sec id="Sec12_3"><title>Plaque Inhibition Assay</title><p>For plaque inhibition assays, confluent monolayer MDCK cells cultured in a 6-well tissue culture plate (1 &#x02009;&#x000d7; &#x02009;10<sup>5</sup> cells/cm<sup>2</sup>) are infected with a mixture of approximately 500 PFU/ml of virus. After 60 min for virus adsorption, the solution is removed and the cells are washed twice with pre-warmed MEM medium, and replaced with overlay medium (DMEM containing 10 &#x003bc;g/ml trypsin, 1% low melting agarose, without serum), containing test compounds/extracts at different concentration. After incubating cultures for 2&#x02013;3 days at 37&#x000b0;C with 5% CO<sub>2</sub>, monolayers are fixed with 4% formaldehyde solution for 30 min and the agarose is then removed by flowing water and stained with 1% (w/v) crystal violet solution. The plaques are counted by visual examination and percentage of plaque inhibition is calculated as relative to the control without samples. A required concentration to reduce the 50% plaque number (EC<sub>50</sub>), is calculated by regression analysis of the dose&#x02013;response curves generated from these data (Song et al. <xref ref-type="bibr" rid="CR166_3">2005</xref>).</p></sec><sec id="Sec13_3"><title>Influenza Virus Quantitative RT-PCR Analysis</title><p>MDCK cells are grown at about 90% confluence and infected with influenza virus at 0.1 MOI and cultured in the presence of compounds/extracts at various concentrations. At 16 h post-infection, cells are scraped off and collected by centrifugation (500 g for 5 min). Cell pellets are washed with PBS twice. Total cellular and viral RNAs are isolated from pellets using the RNeasy mini kit (QIAGEN) following the manufacture&#x02019;s protocol. First-strand cDNA is synthesized from 1 &#x003bc;g of total RNA with Omniscript RT kit (QIAGEN) using specific primers. PCR reactions are performed with 50 &#x003bc;l of reaction buffer [5 &#x003bc;l of cDNA template, 50 pmols of primers, 0.1 mM dNTPs, and 0.5U of EX-Taq polymerase (Takara)]. The amplification conditions are as follows: 94&#x000b0;C for 5 min (1 cycle), 94&#x000b0;C for 1 min, 55&#x000b0;C 40 s and 72&#x000b0;C 1 min 40 s (18 cycles, respectively). NP RNA is chosen for detection and the primer sequences used for the detection of viral RNA are 5&#x02032;-TGC TGG ATT CTC GTT CGG TC (sense) and 5&#x02032;-CCT TTA TGA CAA AGA AGA AATAAGGCG (antisense). The &#x003b2;-actin is used as internal control of cellular RNAs, with primer sequences of 5&#x02032;-TCA CCC GAG TCC ATC ACG AT (sense) and 5&#x02032;-GAA GTA CCC CAT TGA GCA CGG (antisense). The reverse transcription and PCR products are resolved on 1.0% agarose gels and stained with ethidium bromide (Song et al. <xref ref-type="bibr" rid="CR166_3">2005</xref>).</p></sec><sec id="Sec14_3"><title>Enzyme Linked Immunosorbent Assay (ELISA)</title><p>ELISA assays allow the detection of viral antigen or antibody, using a solid-phase assay system. Although qualitative, it offers a rapid, sensitive, and specific method for detection and gross quantitation of virus. Absolute quanitation is possible if a series of pre-determined viral titres are used to get elisa readings and matched with that unknown samples can be calculated to estimate the quantity of the virus samples (untreated or drug-treated). The method cannot differentiate between infectious and non-infectious virus particles as a result of which the drug affecting at the earlier or latter stage of viral replication or maturation may not be understood (Chattopadhyay et al. <xref ref-type="bibr" rid="CR27_3">2009</xref>).</p><p>Briefly, the untreated or drug-treated cells are infected with a known concentration of virus, adsorbed for 1 h, washed and incubated for 2&#x02013;4 days depending on virus-induced CPE. Virus is harvested after freeze-thawing, centrifuged, and supernatant is diluted with the sample diluent and used for ELISA experiments. To each of the 96 well strip-plate coated with virus specific antibody 100 &#x003bc;l control or test sample is added followed by 1 h incubation at room temperature with 100 &#x003bc;l conjugate containing enzyme labeled virus-specific antibody. After washing five times 100 &#x003bc;l of substrate is added and incubated in dark for 10 min at room temperature. Most of the assays employ horseradish peroxidase, alkaline phosphatase, or &#x003b2;-D-galactosidase. Reaction is stopped with stop solution in kit (usually 5% H<sub>2</sub>SO<sub>4</sub>) and absorbance reading is taken photometrically at OD<sub>450</sub>. Alternatively, the drug treatment and virus infection can be performed in 96-well formats, instead of preparing virus supernatants. For this, quadruplicate monolayers in 96-well microtitre plates are overlaid with log10 dilution of test compounds followed by the infection with virus. After 16&#x02013;20 h incubation at 37&#x000b0;C, monolayers are fixed with 0.05% glutaraldehyde in PBS and assayed for protein specific for the virus on the cell surface. ELISA is performed with monoclonal antibodies (MAb) to specific protein of the corresponding virus strains and protein A horseradish peroxidase conjugate (Bio Rad, Hercules, CA). The optical densities (OD<sub>450</sub>) are measured and expressed as a percentage of nondrug-treated virus-infected cells (virus control). The concentration causing 50% reduction in optical density values (EC<sub>50</sub>) was evaluated from graphic plots. The selectivity index (SI) was determined from the ratio of IC<sub>50</sub>:EC<sub>50</sub>.</p></sec></sec></sec><sec id="Sec15_3"><title>Antiviral Activities of Different Phytochemicals</title><p>The ever increasing resistance of human pathogens to current anti-infective agents is a serious medical problem, leading to the need to develop novel antibiotic prototype molecules. In the case of viruses, the search for antiviral agents involves additional difficulties, particularly due to the nature of the infectious viruses. Thus, many compounds that may cause the death of viruses are also very likely to injure the host cell that haibours them. Natural products are increasingly appreciated as leads for drug discovery and development. Screening studies have been carried out in order to find antiviral agents from natural sources, and the extracts of traditional medicinal plants, marine organisms and fungi often show antiviral activities. The evidence indicates that there may be numerous potentially useful antiviral phytochemicals in nature, waiting to be evaluated and exploited. In addition, other plants, not previously utilized medicinally, may also reveal antivirals. Compounds from medicinal plants are of interest as possible source to control viral infection, which include flavonoids, alkaloids, polysaccharides, organic acids, essential oils, and others. Natural substances offer interesting pharmacological perspectives for antiviral drug development in regard to broad-spectrum antiviral properties and novel mechanisms of action.</p><sec id="Sec16_3"><title>Polysaccharides</title><p>Among natural antiviral agents, recent investigations have reconsidered the interest of phyto-polysaccharides, which act as potent inhibitors of different viruses (Martinez et al. <xref ref-type="bibr" rid="CR120_3">2005</xref>). This section will illustrate a variety of antiviral polysaccharides from natural sources since 1990, with the aim of making this matter more accessible to drug development, some typical examples of such medicines and their antiviral activities are shown in Table <xref rid="Tab3_3" ref-type="table">3.3</xref>.<table-wrap id="Tab3_3"><label>Table 3.3</label><caption><p>Summary of the most active polysaccharides from medicinal plants</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Compounds</th><th>Anti-viral effect</th><th>Examples of plant source</th><th>Reference</th></tr></thead><tbody><tr><td>Sulfated polysaccharide fraction</td><td>Exerted activity against HSV-2, HCMV, RSV, influenza A and B virus</td><td>
<italic>Nothogenia fastigiata</italic>
</td><td>Damonte et al. (<xref ref-type="bibr" rid="CR38_3">1994</xref>)</td></tr><tr><td>A polysaccharide</td><td>Exhibited activities against HSV-1</td><td>
<italic>Sclerotium glucanicum</italic>
</td><td>Marchetti et al. (<xref ref-type="bibr" rid="CR119_3">1996</xref>)</td></tr><tr><td>A polysaccharide</td><td>Exhibited activities against HSV</td><td>
<italic>Prunella vulgaris</italic>
</td><td>Xu et al. (<xref ref-type="bibr" rid="CR187_3">1999</xref>)</td></tr><tr><td>A polysaccharide</td><td>Exhibited activities against HIV</td><td>
<italic>Rhizophora mucronata</italic>
</td><td>Premanathan et al. (<xref ref-type="bibr" rid="CR140_3">1999</xref>b)</td></tr><tr><td>A polysaccharide</td><td>Exhibited activities against HSV</td><td>
<italic>Achyrocline flaccida</italic>
</td><td>Garcia et al. (<xref ref-type="bibr" rid="CR57_3">1999</xref>)</td></tr><tr><td>Sulfated galactans</td><td>Exhibited antiviral activity against HSV-1 and HSV-2</td><td>
<italic>Bostrychia montagnei</italic>
</td><td>Duarte et al. (<xref ref-type="bibr" rid="CR47_3">2001</xref>)</td></tr><tr><td>An acidic polysaccharides fraction (APS)</td><td>Exhibited activities against the replication of HSV-2 and VSV</td><td>
<italic>Cedrela tubiflora</italic>
</td><td>Craig et al. (<xref ref-type="bibr" rid="CR35_3">2001</xref>)</td></tr><tr><td>Sulfated polysaccharides</td><td>Exhibited activities against DENV-2 and DENV-3</td><td>
<italic>Gymnogongrus griffithsiae</italic> and <italic>Cryptonemia crenulata</italic>
</td><td>Talarico et al. (<xref ref-type="bibr" rid="CR172_3">2005</xref>)</td></tr><tr><td>Protein bound polysaccharides</td><td>Exhibited potent HSV-1 and HSV-2 antiviral activity</td><td>
<italic>Ganoderma lucidum</italic>
</td><td>Eo et al. (<xref ref-type="bibr" rid="CR48_3">2000</xref>) and Liu et al. (<xref ref-type="bibr" rid="CR109_3">2004</xref>)</td></tr><tr><td>Sulfated polysaccharide</td><td>Exhibited antiviral activity against HSV-1 and HSV-2 both <italic>in vitro</italic> and <italic>in vivo</italic>
</td><td>
<italic>Porphyridium</italic> sp.</td><td>Huheihel et al. (<xref ref-type="bibr" rid="CR70_3">2002</xref>)</td></tr><tr><td>Polysaccharide fractions</td><td>Exhibited antiviral activity against HSV-1 and HIV-1</td><td>
<italic>Arthrospira platensis</italic>
</td><td>Rechter et al. (<xref ref-type="bibr" rid="CR141_3">2006</xref>)</td></tr><tr><td>Polysaccharide fractions</td><td>Exhibited antiviral activity against HSV</td><td>
<italic>Grateloupia indica</italic>
</td><td>Chattopadhyay et al.( <xref ref-type="bibr" rid="CR26_3">2007</xref>)</td></tr><tr><td>Polysaccharide extract</td><td>Displayed activity against WSN influenza A <italic>in vivo</italic>
</td><td>
<italic>Echinacea purpurea</italic>
</td><td>Fusco et al. (<xref ref-type="bibr" rid="CR55_3">2010</xref>)</td></tr></tbody></table></table-wrap>
</p><p>The inhibitory effects of polyanionic substances on the replication of HSV and other viruses were reported almost five decades ago. Shortly after the identification of HIV as the causative agent of AIDS in 1984, heparin and other sulfated polysaccharides were found to be potent and selective inhibitors of HIV-1 replication in cell culture. Since 1988, the activity spectrum of the sulfated polysaccharides has been shown to extend to various enveloped viruses, including HSV <italic>in vitro</italic> (Karmakar et al. <xref ref-type="bibr" rid="CR81_3">2010</xref>; Herold et al. <xref ref-type="bibr" rid="CR65_3">1995</xref>), human cytomegalovirus (HCMV) (Baba et al. <xref ref-type="bibr" rid="CR13_3">1988</xref>), respiratory syncytial virus, influenza A and B virus (Damonte et al. <xref ref-type="bibr" rid="CR38_3">1994</xref>), DENV-2 and DENV-3 in the human hepatoma HepG2 (Talarico et al. <xref ref-type="bibr" rid="CR172_3">2005</xref>).</p><p>As potential anti-HIV drug candidates, sulfated polysaccharides offer a number of promising features. Some polysulfates show a differential inhibitory activity against different HIV strains, suggesting that marked differences exist in the target molecules with which polysulfates interact. They not only inhibit the cytopathic effect of HIV, but also prevent HIV-induced syncytium (giant cell) formation. Furthermore, experiments carried out with sulfate samples of increasing molecular weight and with sulfated cyclodextrins of different degrees of sulfation have shown that antiviral activity increases with increasing molecular weight and degree of sulfation (Duarte et al. <xref ref-type="bibr" rid="CR47_3">2001</xref>; Wang et al. <xref ref-type="bibr" rid="CR181_3">2010</xref>; Karmakar et al. <xref ref-type="bibr" rid="CR81_3">2010</xref>). A sugar backbone is not strictly needed for the anti-HIV activity of polysulfates because sulfated polymers composed of a carbon&#x02013;carbon backbone have also proved to be highly efficient anti-HIV agents <italic>in vitro</italic>. Other, yet to be defined, structural features may also play an important role. From studies on their mechanism of action, polysulfates appear to exert their anti-HIV activity by shielding off the positively charged sites in the V3 loop of the viral envelope glycoprotein (gp120), which is necessary for virus attachment to cell surface heparan sulfate, a primary binding site, before more specific binding occurs to the CD4 receptor of CD4<sup>+</sup> cells (Huheihel et al. <xref ref-type="bibr" rid="CR70_3">2002</xref>). This general mechanism also explains the broad antiviral activity of polysulfates against enveloped viruses. Variations in the viral envelope glycoprotein region may result in differences in the susceptibility of different enveloped viruses to compounds that interact with their envelope glycoproteins. The efficacy of sulfated polysaccharide against herpes simplex virus types 1 and 2 (HSV-1 and -2) were demonstrated <italic>in vivo</italic> (rats and rabbits) (Huheihel et al. <xref ref-type="bibr" rid="CR70_3">2002</xref>).</p><p>The proteoglycan seems to be a potential candidate for anti-HSV agents. A proteoglycan (GLPG), extracted and purified from the mycelia of <italic>Ganoderma lucidum</italic> by ethanol (EtOH) precipitation and DEAE-cellulose column chromatography, displayed antiviral activities against HSV-1 and type 2 (HSV-2). The study on its action mechanism suggested that GLPG inhibits viral replication by interfering with the early events of viral adsorption and entry into target cells (Liu et al. <xref ref-type="bibr" rid="CR109_3">2004</xref>).</p><p>The <italic>in vivo</italic> anti-viral activity has partially been demonstrated (Fusco et al. <xref ref-type="bibr" rid="CR55_3">2010</xref>). The <italic>in vivo</italic> experiment of polysaccharide extract from <italic>Echinacea purpurea</italic>, a widely consumed botanical product, indicated that mice infected with WSN influenza A and treated with <italic>E. purpurea</italic> polysaccharide extract had less weight loss than untreated mice but similar pulmonary viral titers. <italic>Echinacea</italic>-treated mice had lower systemic and pulmonary KC and IL-10 levels and lower systemic IFN-&#x003b3; levels following influenza infection. These suggest that <italic>E. purpurea</italic> alters the clinical course of influenza infection in mice through modulation of cytokines and not direct antiviral activity<bold>.</bold>
</p></sec><sec id="Sec17_3"><title>Flavonoids</title><p>Flavonoids are very common natural products widely existing in plant kingdom. Flavonoids, including genistein, catechins and so on, have been shown to reduce the infectivity of a variety of viruses affecting humans and animals, including adenovirus, HSV, HIV, porcine reproductive and respiratory syndrome virus, and rotavirus (Andres et al. <xref ref-type="bibr" rid="CR7_3">2009</xref>). Current results about the mechanisms of action underlying their antiviral properties suggest a combination of effects on both the virus and the host cell. Flavonoids have been reported to affect virus binding, entry, replication, viral protein translation, formation of certain virus envelope glycoprotein complexes and virus release (Andres et al. <xref ref-type="bibr" rid="CR7_3">2009</xref>). They also affect a variety of host cell signaling processes, including induction of gene transcription factors and secretion of cyto&#x000ad;kines (Andres et al. <xref ref-type="bibr" rid="CR7_3">2009</xref>). Although enormous promising results were from <italic>in vitro</italic> experiments, a few <italic>in vivo</italic> results can partly confirm their <italic>in vivo</italic> efficacy (Miki et al. <xref ref-type="bibr" rid="CR127_3">2007</xref>). Flavonoids possess antiviral properties against a wide range of viruses under both <italic>in vitro</italic> and <italic>in vivo</italic>conditions (see Table <xref rid="Tab4_3" ref-type="table">3.4</xref> and Fig. <xref rid="Fig1_3" ref-type="fig">3.1</xref>).<table-wrap id="Tab4_3"><label>Table 3.4</label><caption><p>Viruses inhibited by flavonoids</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Flavonoids</th><th>Inhibited viruses</th><th>Model</th><th>Reference</th></tr></thead><tbody><tr><td rowspan="5">Catechins</td><td>Adenovirus</td><td>Hep2 cells</td><td>Webster et al. (<xref ref-type="bibr" rid="CR183_3">2006</xref>)</td></tr><tr><td>Influenza virus</td><td>MDCK cells</td><td>Song et al. (<xref ref-type="bibr" rid="CR166_3">2005</xref>)</td></tr><tr><td>HIV-1</td><td>T cells</td><td>Williamson et al. (<xref ref-type="bibr" rid="CR184_3">2006</xref>)</td></tr><tr><td>HSV</td><td>Vero and CV1 cells</td><td>Isaacs et al. (<xref ref-type="bibr" rid="CR71_3">2008</xref>)</td></tr><tr><td>HPV</td><td>Human condyloma</td><td>Reuter et al. (<xref ref-type="bibr" rid="CR144_3">2010</xref>)</td></tr><tr><td rowspan="13">Genistein</td><td>Adenovirus</td><td>SW480 cell</td><td>Li et al. (<xref ref-type="bibr" rid="CR100_3">2000</xref>
<xref ref-type="bibr" rid="CR101_3">b</xref>)</td></tr><tr><td>Arenaviruses</td><td>Vero cells</td><td>Vela et al. (<xref ref-type="bibr" rid="CR174_3">2008</xref>)</td></tr><tr><td>BHV-1</td><td>MDBK cells</td><td>Akula et al. (<xref ref-type="bibr" rid="CR002_3">2002</xref>)</td></tr><tr><td>Bovine viral diarrhea virus</td><td>MDBK cells</td><td>Lecot et al. (<xref ref-type="bibr" rid="CR96_3">2005</xref>)</td></tr><tr><td>EBV</td><td>Ramos cells</td><td>Fukuda and Longnecker (<xref ref-type="bibr" rid="CR54_3">2005</xref>)</td></tr><tr><td>HSV-1, HSV-2</td><td>Vero cells</td><td>Yura et al. (<xref ref-type="bibr" rid="CR193_3">1993</xref>) and Lyu et al. (<xref ref-type="bibr" rid="CR116_3">2005</xref>)</td></tr><tr><td>Human CMV</td><td>HEL 299 cells</td><td>Evers et al. (<xref ref-type="bibr" rid="CR50_3">2005</xref>)</td></tr><tr><td>HHV-8</td><td>HFF cells</td><td>Sharma-Walia et al. (<xref ref-type="bibr" rid="CR158_3">2004</xref>)</td></tr><tr><td>HIV</td><td>Primary macrophages</td><td>Stantchev et al. (<xref ref-type="bibr" rid="CR169_3">2007</xref>)</td></tr><tr><td>MoMLV</td><td>XC cells</td><td>Kubo et al. (<xref ref-type="bibr" rid="CR90_3">2003</xref>)</td></tr><tr><td>RSV</td><td>Vero cells</td><td>Rixon et al. (<xref ref-type="bibr" rid="CR146_3">2005</xref>)</td></tr><tr><td>Rotavirus</td><td>MA-104 cells</td><td>Andres et al. (<xref ref-type="bibr" rid="CR6_3">2007</xref>)</td></tr><tr><td>SV40</td><td>CV-1 cells</td><td>Dangoria et al. (<xref ref-type="bibr" rid="CR39_3">1996</xref>) and Pelkmans et al. (<xref ref-type="bibr" rid="CR137_3">2002</xref>)</td></tr><tr><td rowspan="2">Quercetin</td><td>Adenovirus</td><td>BCC-1/KMC cells</td><td>Chiang et al. (<xref ref-type="bibr" rid="CR30_3">2003</xref>
<xref ref-type="bibr" rid="CR31_3">b</xref>)</td></tr><tr><td>Coronovirus</td><td>Vero cells</td><td>Yi et al. (<xref ref-type="bibr" rid="CR191_3">2004</xref>)</td></tr><tr><td rowspan="2">Luteolin</td><td>Coronovirus</td><td>Vero cells</td><td>Yi et al. (<xref ref-type="bibr" rid="CR191_3">2004</xref>)</td></tr><tr><td>Influenza virus</td><td>MDCK cells</td><td>Liu et al. (<xref ref-type="bibr" rid="CR110_3">2008a</xref>)</td></tr><tr><td>Apigenin</td><td>Influenza virus</td><td>MDCK cells</td><td>Liu et al. (<xref ref-type="bibr" rid="CR110_3">2008a</xref>)</td></tr><tr><td>3-Deoxysappanchalcone</td><td>Influenza virus</td><td>MDCK cells</td><td>Liu et al. (<xref ref-type="bibr" rid="CR112_3">2009</xref>)</td></tr><tr><td>Sappanchalcone</td><td>Influenza virus</td><td>MDCK cells</td><td>Liu et al. (<xref ref-type="bibr" rid="CR112_3">2009</xref>)</td></tr><tr><td>Isoflavones mix</td><td>PRRS virus</td><td>Pigs (<italic>in vivo</italic>)</td><td>Greiner et al. (<xref ref-type="bibr" rid="CR60_3">2001</xref>)</td></tr><tr><td>Gorvanol A</td><td>HSV-1</td><td>Vero cells</td><td>Arthan et al. (<xref ref-type="bibr" rid="CR9_3">2002</xref>)</td></tr><tr><td>Kaempferol</td><td>HSV-1</td><td>Vero cells</td><td>Amoros et al. (<xref ref-type="bibr" rid="CR4_3">1992</xref>)</td></tr><tr><td>5,6,7-Trimethoxyflavone</td><td>HSV-1, Human CMV, Poliovirus</td><td>Vero and MRC-5 cells</td><td>Hayashi et al. (<xref ref-type="bibr" rid="CR63_3">1997</xref>)</td></tr><tr><td>Irisolidone</td><td>JC virus</td><td>Primary astrocytes</td><td>Kim et al. (<xref ref-type="bibr" rid="CR84_3">2006</xref>)</td></tr><tr><td>3-Methylkaempferol</td><td>Poliovirus</td><td>Vero cells</td><td>Robin et al. (<xref ref-type="bibr" rid="CR147_3">2001</xref>)</td></tr><tr><td>3(2H)-isoflavene</td><td>Poliovirus</td><td>HeLa R19 cells</td><td>Salvati et al. (<xref ref-type="bibr" rid="CR148_3">2004</xref>)</td></tr><tr><td>Pedunculosumosides A and G</td><td>Human B Virus (HBV)</td><td>HepG2 2.2.15 cells</td><td>Wan et al. (<xref ref-type="bibr" rid="CR178_3">2011</xref>)</td></tr></tbody></table></table-wrap>
<fig id="Fig1_3"><label>Fig. 3.1</label><caption><p>The chemical structures of the active flavonoids from medicinal plants</p></caption><graphic xlink:href="301425_1_En_3_Fig1a_HTML" id="d29e2355"/><graphic xlink:href="301425_1_En_3_Fig1b_HTML" id="d29e2356"/><graphic xlink:href="301425_1_En_3_Fig1c_HTML" id="d29e2357"/></fig>
</p><p>Tea polyphenols from green tea mainly consist of catechins ((&#x02212;)-epigallocatechin gallate (EGCG), (&#x02212;)-epicatechin gallate (ECG) and (&#x02212;)-epigallocatechin (EGC)). Their ability to inhibit several different viruses was evaluated. Among the catechins, the EGCG and ECG were found to be potent inhibitors of influenza virus replication in MDCK cell culture and this effect was observed in all influenza virus subtypes tested, including A/H1N1, A/H3N2 and B virus (Demeule et al. <xref ref-type="bibr" rid="CR42_3">2002</xref>). However, the sensitivity in hemagglutination inhibition was widely different among three different subtypes of influenza viruses tested. Quantitative RT-PCR analysis revealed that, at high concentration, EGCG and ECG also suppressed viral RNA synthesis in MDCK cells whereas EGC failed to show similar effect (Song et al. <xref ref-type="bibr" rid="CR166_3">2005</xref>). Similarly, EGCG and ECG inhibited the neuraminidase activity more effectively than the EGC (Song et al. <xref ref-type="bibr" rid="CR166_3">2005</xref>). The results show that the 3-galloyl group of catechin skeleton plays an important role on the observed antiviral activity, whereas the 5&#x02032;-OH at the trihydroxy benzyl moiety at 2-position plays a minor role (Song et al. <xref ref-type="bibr" rid="CR166_3">2005</xref>). In addition, EGCG has not only potential use as adjunctive therapy in HIV-1 infection (Williamson et al. <xref ref-type="bibr" rid="CR184_3">2006</xref>), but has greater anti-HSV activity than other green tea catechins and inactivates multiple clinical isolates of HSV-1 and HSV-2 by binding to gB, gD, or another envelope glycoprotein, it appears to be a promising candidate for use in a microbicide to reduce HSV transmission (Isaacs et al. <xref ref-type="bibr" rid="CR71_3">2008</xref>). Among green tea chatechins, EGCG was the most effective when added to the cells during the transition from the early to the late phase of adenovirus infection, suggesting that EGCG inhibits one or more late steps in virus infection (Webster et al. <xref ref-type="bibr" rid="CR183_3">2006</xref>). It is worth to mention that Veregen (80% catechins) as a prescription drug for condyloma treatment was approved by US FDA in 2006, suggesting that medicinal plants will open up new prospects for the pharmaceutical industry (Reuter et al. <xref ref-type="bibr" rid="CR144_3">2010</xref>).</p><p>The flavonoids apigenin and luteolin displayed significant <italic>in vitro</italic> anti-influenza viral activity, which were isolated from the traditional Chinese medicinal plant <italic>Elsholtzia rugulosa</italic> Hemsl. (Liu et al. <xref ref-type="bibr" rid="CR110_3">2008a</xref>). The structure-activity relationship (SAR) of flavonoids as influenza virus neuraminidase inhibitors revealed that for good inhibitory effect, the 4&#x02032;-OH, 7-OH, C4=O, and C2=C3 functionalities were essential, and the presence of a glycosylation group greatly reduced NA inhibition (Liu et al. <xref ref-type="bibr" rid="CR111_3">2008b</xref>). The ability of flavonoids to inhibit the activity of NA is one of the pathways to inhibit the replication of influenza virus. These findings provide important information for the exploitation and utilization of flavonoids as NA inhibitors for influenza treatment.</p><p>It was reported that rutin, 5,7-dimethoxyflavanone-4&#x02032;-O-&#x003b2;-d-glucopyranoside and 5,7,3&#x02032;-trihydroxy-flavanone- 4&#x02032;-O-&#x003b2;-d-glucopyranoside were active against PI-3 (Parainfluenza-3 virus), while 5,7-dimethoxyflavanone-4&#x02032;-O-[2&#x02033;-O- (5&#x02033;&#x02032;-O-trans-cinnamoyl)-&#x003b2;-d-apiofuranosyl]-&#x003b2;-d- glucopyranoside inhibited potently HSV-1 (Orhan et al. <xref ref-type="bibr" rid="CR134_3">2009</xref>).</p><p>While baicalein and genistein can block human cytomegalovirus (HCMV) replication at concentrations that were significantly lower than those producing cytotoxicity against growing or stationary phase host cells. The study of their mechanisms of action suggested that the primary mechanism of action for baicalein may be to block HCMV infection at entry while the primary mechanism of action for genistein may be to block HCMV immediate-early protein functioning (Evers et al. <xref ref-type="bibr" rid="CR50_3">2005</xref>). Flavonoids orientin and vitexin found in the flower of Chinese folk medicine <italic>Trollius chinensis</italic> Bunge exhibited potent or moderate antiviral activity against PI-3 (Li et al. <xref ref-type="bibr" rid="CR103_3">2002</xref>).</p><p>The flavonoid chrysosplenol C yielded from the green aerial parts of the Australian plant <italic>Pterocaulon sphacelatum</italic> (Labill.) Benth. and Hook. f. ex F. Muell., which is a 4&#x02032;-hydroxy-3-methoxyflavone, has the ability to inhibit the replication of rhinoviruses (Semple et al. <xref ref-type="bibr" rid="CR152_3">1999</xref>). While the antiviral activity of quercetin 3-rhamnoside (Q3R) from traditional Chinese medicine <italic>Houttuynia cordata</italic> was evaluated using a cytopathic effect (CPE) reduction method, the assay results demonstrated that Q3R possessed strong anti-influenza A/WS/33 virus reducing the formation of a visible CPE. In addition, Q3R inhibited virus replication in the initial stage of virus infection by indirect interaction with virus particles. Therefore, these findings provide important information for the utilization of Q3R for influenza treatment (Choi et al. <xref ref-type="bibr" rid="CR32_3">2009</xref>
<xref ref-type="bibr" rid="CR33_3">b</xref>).</p><p>Flavonoid luteoforol isolated from <italic>Hypericum connatum</italic> (Guttiferae), which is used in southern Brazil in the treatment of lesions in the mouth and often related to acute herpetic gingivo-stomatitis, displayed antiviral activity against HSV-1 DNA viral strains KOS and VR733 (ATCC) (Fritz et al. <xref ref-type="bibr" rid="CR53_3">2007</xref>). Moreover, flavones are inhibitors of HIV-1 proteinase (Brinkworth et al. <xref ref-type="bibr" rid="CR15_3">1992</xref>).</p><p>Therefore, flavonoids and their structurally similar compounds possess antiviral properties against a wide range of viruses under both <italic>in vitro</italic> and <italic>in vivo</italic> conditions. These findings will provide important information for new drug design and for their exploitation and utilization for the treatment of viral infection.</p></sec><sec id="Sec18_3"><title>Organic Acids</title><p>Besides, some natural organic acids also possess antiviral activities. Three caffe&#x000ad;oyl&#x000ad;quinic acid derivatives, namely 3,4-di-O-caffeoylquinic acid, 3,5-di-O- caffeoylquinic acid, and 3-O-caffeoylquinic acid isolated from traditional Chinese medicinal plant <italic>Schefflera heptaphylla</italic> were investigated for their antiviral activity against RSV (see Fig. <xref rid="Fig2_3" ref-type="fig">3.2</xref>; Li et al. <xref ref-type="bibr" rid="CR104_3">2005</xref>
<xref ref-type="bibr" rid="CR105_3">b</xref>). 3,4-Di-O-caffeoylquinic acid and 3,5-di-O- caffeoylquinic acid exhibited potent anti-RSV activity with IC<sub>50</sub> values of 2.33 &#x003bc;M (1.2 &#x003bc;g/ml) and 1.16 &#x003bc;M (0.6 &#x003bc;g/ml), respectively, in a plaque reduction assay. The antiviral action of 3,4-di-O-caffeoylquinic acid and 3,5-di-O-caffeoylquinic acid was specific against RSV, as they had no obvious antiviral activity against influenza A (Flu A), Coxsackie B3 (Cox B3), and Herpes simplex type one (HSV-1) viruses (Li et al. <xref ref-type="bibr" rid="CR104_3">2005</xref>
<xref ref-type="bibr" rid="CR105_3">b</xref>). Studies indicated that the dicaffeoylquinic acids could inhibit RSV directly, extracellularly, but only at much higher concentrations than seen in standard assays. Moreover, they could not inhibit RSV attachment to host cells, and could not protect HEp-2 cells from RSV infection at lower concentrations. The data suggest that the compounds exert their anti-RSV effects via the inhibition of virus&#x02013;cell fusion in the early stage, and the inhibition of cell&#x02013;cell fusion at the end of the RSV replication cycle (Li et al. <xref ref-type="bibr" rid="CR104_3">2005</xref>
<xref ref-type="bibr" rid="CR105_3">b</xref>).<fig id="Fig2_3"><label>Fig. 3.2</label><caption><p>The chemical structures of the active organic acids from medicinal plants</p></caption><graphic xlink:href="301425_1_En_3_Fig2_HTML" id="MO2_3"/></fig>
</p><p>Raoulic acid is a principal ingredient of the plant <italic>Raoulia australis</italic> Hook. F (Fig. <xref rid="Fig2_3" ref-type="fig">3.2</xref>; Choi et al. <xref ref-type="bibr" rid="CR32_3">2009a</xref>). Antiviral assay using cytopathic effect (CPE) reduction method showed that raoulic acid possessed strong antiviral activity against human rhinovirus 2 (HRV2) with IC<sub>50</sub> value of less than 0.1 &#x003bc;g/ml, human rhinovirus 3 (HRV3) with a IC<sub>50</sub> value of 0.19 &#x003bc;g/ml, coxsackie B3 (CB3) virus with IC<sub>50</sub> values of 0.33 &#x003bc;g/ml, coxsackie B4 (CB4) virus with IC<sub>50</sub> values of 0.40 &#x003bc;g/ml, and enterovirus 71 (EV71) virus with IC<sub>50</sub> values of less than 0.1 &#x003bc;g/ml. However, the compound did not possess antiviral activity against influenza A (Flu A/PR, Flu A/WS, H1N1) and B viruses.</p><p>Moreover, the antiviral activity of aqueous extract and pure compounds of <italic>Plantago major</italic> L., a popular traditional Chinese medicine, were studied on a series of viruses, namely herpesviruses (HSV-1, HSV-2) and adenoviruses (ADV-3, ADV-8, ADV-11). The results showed that aqueous extract of <italic>P. major</italic> possessed only a slight anti-herpes virus activity (Wang et al. <xref ref-type="bibr" rid="CR180_3">2009</xref>). While certain pure compounds exhibited potent antiviral activity. Among them, caffeic acid exhibited the strongest activity against HSV-1 (EC<sub>50</sub> &#x02009;= &#x02009;15.3 &#x003bc;g/ml, SI &#x02009;= &#x02009;671), HSV-2 (EC<sub>50</sub> &#x02009;= &#x02009;87.3 &#x003bc;g/ml, SI &#x02009;= &#x02009;118) and ADV-3 (EC<sub>50</sub> &#x02009;= &#x02009;14.2 &#x003bc;g/ml, SI &#x02009;= &#x02009;727), whereas chlorogenic acid possessed the strongest anti-ADV-11 (EC<sub>50</sub> &#x02009;= &#x02009;13.3 &#x003bc;g/ml, SI &#x02009;= &#x02009;301) activity (Wang et al. <xref ref-type="bibr" rid="CR180_3">2009</xref>). The study concludes that pure compounds of <italic>P. major</italic>, which possess antiviral activities are mainly derived from the phenolic compounds, especially caffeic acid. Its mode of action against HSV-2 and ADV-3 was found to be at multiplication stages (postinfection of HSV-1: 0&#x02013;12 h; ADV-3: 0&#x02013;2 h) (Chiang et al. <xref ref-type="bibr" rid="CR29_3">2002a</xref>). In addition, chlorogenic acid and caffeic acid also showed an inhibitory effect on HBV (hepatitis B virus) replication (Fig. <xref rid="Fig2_3" ref-type="fig">3.2</xref>; Wang et al. <xref ref-type="bibr" rid="CR180_3">2009</xref>).</p></sec><sec id="Sec19_3"><title>Alkaloids</title><p>There are some alkaloids which exhibit antiviral activities both <italic>in vitro</italic> and <italic>in vivo</italic>. The naphthoindozidine alkaloid, together with 7-demethoxytylophorine and 7-demethoxytylophorine N-oxide isolated from the aerial parts of <italic>Cynanchum komarovii</italic>, had antiviral activities against tobacco mosaic virus (An et al. <xref ref-type="bibr" rid="CR5_3">2001</xref>). While the sophoridine is one of the active constituents extracted from Chinese medicinal herb, <italic>Sophora flavescens</italic>, exhibited significantly antiviral activity against coxsackievirus B3 (CVB3) <italic>in vitro</italic> (primarily cultured myocardial cells) and <italic>in vivo</italic> (BALB/c mice) by regulating cytokine expression, and it is likely that sophoridine itself, not its metabolites, is mainly responsible for the antiviral activities (Zhang et al. <xref ref-type="bibr" rid="CR195_3">2006</xref>). While another alkaloid lycorine, isolated from <italic>Lycoris radiate</italic> possesses anti-SARS-CoV activity (Fig. <xref rid="Fig3_3" ref-type="fig">3.3</xref>; Li et al. <xref ref-type="bibr" rid="CR104_3">2005a</xref>).<fig id="Fig3_3"><label>Fig. 3.3</label><caption><p>The chemical structures of the active alkaloids from medicinal plants</p></caption><graphic xlink:href="301425_1_En_3_Fig3_HTML" id="MO3_3"/></fig>
</p></sec><sec id="Sec20_3"><title>Saponins</title><p>Plant saponins are a group of naturally occurring triterpene or steroid glycosides which include a large number of biologically and pharmacologically active compounds. Saponins have been shown in both <italic>in vitro</italic> and <italic>in vivo</italic> experimental test systems during the last decade to possess a broad spectrum of biological and pharmacological activities. This section will summarize some of the recent advances concerning antiviral activities of saponins.</p><p>The antiviral activity of a triterpene saponin isolated from <italic>angallis arvensis</italic>, was studied <italic>in vitro</italic> against several viruses including HSV-1, adenovirus type 6, vaccinia, vesicular stomatitis and poliovirus (Amoros et al. <xref ref-type="bibr" rid="CR3_3">1987</xref>). The drug was found to inhibit the replication of HSV-1 and poliovirus type 2 as shown by inhibition of cytopathic effect and reduction of virus production. The action was not due to a virucidal effect but might involve inhibition of virus-host cell attachment. Single cycle experiments indicated that saponins interfered with both early and late events of herpes virus replication (Amoros et al. <xref ref-type="bibr" rid="CR3_3">1987</xref>).</p><p>The Tibetan herb <italic>Potentilla anserina</italic> L. has been widely used in China for many thousands of years to treat hepatitis-B. Bioassay-guided fractionation of the ethanol extract of the rhizomes led to the isolation of a triterpenoid saponin (TS) that was determined to be 2<italic>&#x003b1;</italic>,3<italic>&#x003b2;</italic>,19<italic>&#x003b1;</italic>-trihydroxyurs-12-en-28-oic acid <italic>&#x003b2;</italic>-d-glucopyranosyl ester (Fig. <xref rid="Fig4_3" ref-type="fig">3.4</xref>; Zhao et al. <xref ref-type="bibr" rid="CR197_3">2008</xref>). Using models of HBV infection, this compound was evaluated for its effect on HBV antigene expression in the 2.2.15 cell line <italic>in vitro</italic> and anti-hepatitis B virus (HBV) activities in Peking ducklings <italic>in vivo</italic> (Zhao et al. <xref ref-type="bibr" rid="CR197_3">2008</xref>). Results showed that it could decrease the expression levels of HBsAg, HBeAg and HBVDNA in the 2.2.15 cell culture. The antiviral study <italic>in vivo</italic> on Peking ducklings also demonstrated that this compound inhibits duck hepatitis B virus (DHBV) DNA replication (Zhao et al. <xref ref-type="bibr" rid="CR197_3">2008</xref>).<fig id="Fig4_3"><label>Fig. 3.4</label><caption><p>The chemical structure of the most active saponin from <italic>Potentilla anserina</italic> L.</p></caption><graphic xlink:href="301425_1_En_3_Fig4_HTML" id="MO4_3"/></fig>
</p></sec><sec id="Sec21_3"><title>Essential Oils</title><p>The application of essential oils as possible therapeutic agents against diseases is gaining attention due to various factors. Growing consumer preferences for inexpensive, natural and traditional medicines that are also effective on resistant bacterial or viral strains have stimulated investigations into the bioactive properties of essential oils. This section will summarize some of the recent advances concerning antiviral activities of essential oils.</p><p>The <italic>Artemisia arborescens</italic> L. essential oil showed significant antiviral activity against Herpes simplex virus type 1 (HSV-1) (Sinico et al. <xref ref-type="bibr" rid="CR163_3">2005</xref>). Peppermint oil, the essential oil of <italic>Mentha piperita</italic>, exhibited high levels of virucidal activity against HSV-1 and HSV-2, and it is also active against an acyclovir resistant strain of HSV-1 (HSV-1-ACV<sup>res</sup>) (Schuhmacher et al. <xref ref-type="bibr" rid="CR151_3">2003</xref>).</p><p>The essential oil from <italic>Santolina insularis</italic> was also inhibited virus replication against HSV-1 and HSV-2 <italic>in vitro</italic> (Schnitzler et al. <xref ref-type="bibr" rid="CR150_3">2008</xref>). Its antiviral activity was principally due to direct virucidal effects (De Logu et al. <xref ref-type="bibr" rid="CR40_3">2000</xref>). Lemon balm oil, the essential oil of <italic>Melissa officinalis</italic>, is capable of exerting a direct antiviral effect on HSV-1 and HSV-2. Considering the lipophilic nature of essential oils, which enable it to penetrate the skin, and a high selectivity index, essential oils might be suitable for topical treatment of herpetic infections (Schnitzler et al. <xref ref-type="bibr" rid="CR150_3">2008</xref>).</p><p>The wood essential oil from <italic>Cedrus libani</italic> widely used as traditional medicine in Lebanon for treatment of different infection diseases are mainly consist of himachalol (22.50%), <italic>&#x003b2;</italic>-himachalene (21.90%), and <italic>&#x003b1;</italic>-himachalene (10.50%) was identified for their <italic>in vitro</italic> antiviral activities against HSV-1 (Fig. <xref rid="Fig5_3" ref-type="fig">3.5</xref>; Loizzo et al. <xref ref-type="bibr" rid="CR114_3">2008</xref>).<fig id="Fig5_3"><label>Fig. 3.5</label><caption><p>The chemical structures of the active essential oils from medicinal plants</p></caption><graphic xlink:href="301425_1_En_3_Fig5_HTML" id="MO5_3"/></fig>
</p><p>All essential oils from anise, hyssop, thyme, ginger, camomile and sandalwood possess virucidal activity against HSV-2 mainly before adsorption probably by interacting with the viral envelope (Koch et al. <xref ref-type="bibr" rid="CR85_3">2008</xref>). Camomile oil exhibited a high selectivity index and seems to be a promising candidate for topical therapeutic application as virucidal agents for treatment of herpes genitalis (Koch et al. <xref ref-type="bibr" rid="CR85_3">2008</xref>).</p></sec><sec id="Sec22_3"><title>Stilbenes</title><p>In recent years, stilbenes, which widely exist in natural kingdom, have attracted much attention for their various biological activities, including antimicrobial, anti-cancer, anti-inflammation, hepatoprotective and hepatotoxic and so on (Liu et al. <xref ref-type="bibr" rid="CR113_3">2010</xref>).</p><p>Resveratrol (3,5,4&#x02032;-trihydroxystilbene) is a natural component of certain foods, such as grapes, has been shown to have anti-HSV activities <italic>in vitro</italic> and <italic>in vivo</italic> (Fig. <xref rid="Fig6_3" ref-type="fig">3.6</xref>; Docherty et al. <xref ref-type="bibr" rid="CR44_3">2004</xref>, <xref ref-type="bibr" rid="CR45_3">2005</xref>). Moreover, resveratrol was found to inhibit varicella-zoster virus (VZV) replication in a dose-dependent and reversible manner (Docherty et al. <xref ref-type="bibr" rid="CR46_3">2006</xref>). Two oligostilbenes dibalanocarpol and balanocarpol isolated from the leaves of <italic>Hopea malibato</italic> exhibited very modest HIV-inhibitory activity <italic>in vitro</italic> (Dai et al. <xref ref-type="bibr" rid="CR37_3">1998</xref>).<fig id="Fig6_3"><label>Fig. 3.6</label><caption><p>The chemical structures of the active stilbenes from medicinal plants</p></caption><graphic xlink:href="301425_1_En_3_Fig6_HTML" id="MO6_3"/></fig>
</p><p>Besides, oligostilbenes also possess antiviral effect. Four stilbenoids, including isorhapontigenin, shegansu B, gnetupendin B and gnetin D from the lianas of <italic>Gnetum pendulum</italic> (Gnetaceae), exhibited significant <italic>in vitro</italic> anti-influenza viral activities in MDCK cells with IC<sub>50</sub> values from 0.67 to 11.99 &#x003bc;g/ml, their action mechanism is mainly through influenza neuraminidase (NA) inhibitory effects (see Fig. <xref rid="Fig6_3" ref-type="fig">3.6</xref>; Liu et al. <xref ref-type="bibr" rid="CR113_3">2010</xref>).</p></sec><sec id="Sec23_3"><title>Others</title><p>In addition, the antiviral activity of several other kinds of natural products was also reported. Terpenoids caesalmin B and bonducellpin D from the seeds of traditional Chinese medicinal plant <italic>Caesalpinia minax</italic> exhibited inhibitory activities on the PI-3 virus <italic>in vitro</italic> by cytopathogenic effects (CPE) reduction assay (Jiang et al. <xref ref-type="bibr" rid="CR78_3">2002</xref>). Hippomanin A from <italic>Phyllanthus urinaria</italic> Linnea (Euphorbiaceae), which is a commonly used traditional medicinal plant in oriental countries, exhibited antiviral activity against HSV-2 but not HSV-1 infection (Fig. <xref rid="Fig7_3" ref-type="fig">3.7</xref>; Yang et al. <xref ref-type="bibr" rid="CR189_3">2007</xref>).<fig id="Fig7_3"><label>Fig. 3.7</label><caption><p>The chemical structures of the other kinds of constituents from medicinal plants</p></caption><graphic xlink:href="301425_1_En_3_Fig7_HTML" id="MO7_3"/></fig>
</p><p>Chrysophanic acid (1,8-dihydroxy-3-methylanthraquinone), isolated from the Australian Aboriginal medicinal plant <italic>Dianella longifolia</italic>, has been found to inhibit the replication of poliovirus types 2 and 3 (<italic>Picornaviridae</italic>) <italic>in vitro</italic> (Fig. <xref rid="Fig7_3" ref-type="fig">3.7</xref>; Semple et al. <xref ref-type="bibr" rid="CR153_3">2001</xref>). The compound inhibited an early stage in the viral replication cycle, but did not have an irreversible virucidal effect on poliovirus particles. Chrysophanic acid did not have significant antiviral activity against five other viruses which were tested: Coxsackievirus types A21 and B4, human rhinovirus type 2 (<italic>Picornaviridae</italic>), and the enveloped viruses Ross River virus (<italic>Togaviridae</italic>) and HSV-1 (<italic>Herpesviridae</italic>). Four structurally-related anthraquinones &#x02013; rhein, 1,8-dihydroxyanthraquinone, emodin (3-methyl-1,6,8-trihydroxyanthraquinone) and aloe-emodin were also tested for activity against poliovirus type 3 (Semple et al. <xref ref-type="bibr" rid="CR153_3">2001</xref>). None of the four compounds was as active as chrysophanic acid against the virus. The results suggested that two hydrophobic positions on the chrysophanic acid molecule (C-6 and the methyl group attached to C-3) were important for the compound&#x02019;s activity against poliovirus (Semple et al. <xref ref-type="bibr" rid="CR153_3">2001</xref>).</p><p>Recently, it was reported that emodin isolated from the roots of <italic>Rheum tanguticum</italic> possess remarkable antiviral activity against HSV infection <italic>in vitro</italic> and <italic>in vivo</italic> (Xiong et al. <xref ref-type="bibr" rid="CR185_3">2011</xref>), and thus emodin is a promising agent in the clinical therapy of HSV infection. Besides, seven new homoflavonoid glucosides, pedunculosumosides A&#x02013;G were isolated from the whole plant of <italic>Ophioglossum pedunculosum</italic>, pedunculosumosides A and C exhibit modest activity of blocking HBsAg secretion with IC<sub>50</sub> values of 238.0 and 70.5 &#x003bc;M, respectively (Wan et al. <xref ref-type="bibr" rid="CR178_3">2011</xref>).</p><p>With increasing of interest in the drug discovery from natural products, more and more antiviral activities of phytochemicals will be reported, which will greatly promote the new drug discovery and development for the treatment of viral infection disease.</p></sec></sec><sec id="Sec24_3"><title>Future Perspective</title><p>Not only the common viral diseases are still fatal, but new viral infections have emerged in worldwide in recent years. The currently available antivirals though effective are too expensive for most developing countries. Thus, the development of safe, effective and inexpensive antiviral drugs is among the top global priorities since many viruses are not yet curable and mortality rates are still high for example with HIV and hepatitis. Because of the tendency of viral mutation to drug-resistant forms, it is essential to continue the search for useful and novel natural antiviral agents, which can be expected to prolong the efficacy of drug therapy. Recently a lot of attention has been given to screening of various species of medicinal plants especially with antiviral activity (Asres et al. <xref ref-type="bibr" rid="CR12_3">2001</xref>; Jassim and Naji <xref ref-type="bibr" rid="CR74_3">2003</xref>; Chattopadhyay et al. <xref ref-type="bibr" rid="CR25_3">2006</xref>, <xref ref-type="bibr" rid="CR27_3">2009</xref>).</p><p>Since an obvious number of plant extracts have showed positive results, it seems reasonable to conclude that there are probably many potential antiviral agents. Further characterization of the active ingredients will reveal useful compounds. Some of these compounds belong to a wide range of different structural classes, e.g. coumarins, flavonoids, tannins, alkaloids, lignans, terpenes, naphtho- and anthraquinones, polysaccharides, proteins and peptides. There may also be novel phytochemicals. Although large numbers of new compounds have been isolated from medicinal plants, only some have been marketed as pharmaceutical products. Several compounds have been or are undergoing various phases of clinical trials. The traditional use of some of the medicinal plants for the treatment of infectious diseases of viral origin, therefore, is justified. In conclusion, active phytochemicals will provide important information for the development of new medicinal plant products in controlling the threats posed by some pathogenic viruses.</p></sec></body><back><ref-list id="Bib1_3"><title>References</title><ref id="CR002_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akula</surname><given-names>SM</given-names></name><name><surname>Hurley</surname><given-names>DJ</given-names></name><name><surname>Wixon</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Effect of genistein on replication of bovine herpesvirus type 1</article-title><source>Am J Vet Res</source><year>2002</year><volume>63</volume><fpage>1124</fpage><lpage>1128</lpage><?supplied-pmid 12171165?><pub-id pub-id-type="pmid">12171165</pub-id></element-citation></ref><ref id="CR3_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amoros</surname><given-names>M</given-names></name><name><surname>Fauconnier</surname><given-names>B</given-names></name><name><surname>Girre</surname><given-names>RL</given-names></name></person-group><article-title>In vitro antiviral activity of a saponin from <italic>Anagallis arvensis</italic>, Primulaceae, against herpes simplex virus and poliovirus</article-title><source>Antiviral Res</source><year>1987</year><volume>8</volume><fpage>13</fpage><lpage>25</lpage><?supplied-pmid 2825589?><pub-id pub-id-type="pmid">2825589</pub-id></element-citation></ref><ref id="CR4_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amoros</surname><given-names>M</given-names></name><name><surname>Simoes</surname><given-names>CM</given-names></name><name><surname>Girre</surname><given-names>L</given-names></name><etal/></person-group><article-title>Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis</article-title><source>J Nat Prod</source><year>1992</year><volume>55</volume><fpage>1732</fpage><lpage>1740</lpage><?supplied-pmid 1338212?><pub-id pub-id-type="pmid">1338212</pub-id></element-citation></ref><ref id="CR5_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>RQ</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Alkaloids from <italic>Cynanchum komarovii</italic> with inhibitory activity against the tobacco mosaic virus</article-title><source>Phytochemistry</source><year>2001</year><volume>58</volume><fpage>1267</fpage><lpage>1269</lpage><?supplied-pmid 11738420?><pub-id pub-id-type="pmid">11738420</pub-id></element-citation></ref><ref id="CR6_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andres</surname><given-names>A</given-names></name><name><surname>Donovan</surname><given-names>SM</given-names></name><name><surname>Kuhlenschmidt</surname><given-names>TB</given-names></name><etal/></person-group><article-title>Isoflavones at concentrations present in soy infant formula inhibit rotavirus infection in vitro</article-title><source>J Nutr</source><year>2007</year><volume>137</volume><fpage>2068</fpage><lpage>2073</lpage><?supplied-pmid 17709444?><pub-id pub-id-type="pmid">17709444</pub-id></element-citation></ref><ref id="CR7_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andres</surname><given-names>A</given-names></name><name><surname>Donovan</surname><given-names>SM</given-names></name><name><surname>Kuhlenschmidt</surname><given-names>MS</given-names></name></person-group><article-title>Soy isoflavones and virus infections</article-title><source>J Nutr Biochem</source><year>2009</year><volume>20</volume><fpage>563</fpage><lpage>569</lpage><?supplied-pmid 19596314?><pub-id pub-id-type="pmid">19596314</pub-id></element-citation></ref><ref id="CR9_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arthan</surname><given-names>D</given-names></name><name><surname>Svasti</surname><given-names>J</given-names></name><name><surname>Kittakoop</surname><given-names>P</given-names></name><etal/></person-group><article-title>Antiviral isoflavonoid sulfate and steroidal glycosides from the fruits of <italic>Solanum torvum</italic></article-title><source>Phytochemistry</source><year>2002</year><volume>59</volume><fpage>459</fpage><lpage>463</lpage><?supplied-pmid 11830167?><pub-id pub-id-type="pmid">11830167</pub-id></element-citation></ref><ref id="CR11_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asres</surname><given-names>K</given-names></name><name><surname>Bucar</surname><given-names>F</given-names></name></person-group><article-title>Anti-HIV activity against immunodeficiency virus type 1 (HIV-I) and type II (HIV-II) of compounds isolated from the stem bark of <italic>Combretum molle</italic></article-title><source>Ethiop Med J</source><year>2005</year><volume>43</volume><fpage>15</fpage><lpage>20</lpage><?supplied-pmid 16370525?><pub-id pub-id-type="pmid">16370525</pub-id></element-citation></ref><ref id="CR12_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asres</surname><given-names>K</given-names></name><name><surname>Bucar</surname><given-names>F</given-names></name><name><surname>Kartnig</surname><given-names>T</given-names></name><etal/></person-group><article-title>Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plants</article-title><source>Phytother Res</source><year>2001</year><volume>15</volume><fpage>62</fpage><lpage>69</lpage><?supplied-pmid 11180526?><pub-id pub-id-type="pmid">11180526</pub-id></element-citation></ref><ref id="CR13_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname><given-names>M</given-names></name><name><surname>Nakajima</surname><given-names>M</given-names></name><name><surname>Schols</surname><given-names>D</given-names></name><etal/></person-group><article-title>Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro</article-title><source>Antiviral Res</source><year>1988</year><volume>9</volume><fpage>335</fpage><lpage>343</lpage><?supplied-pmid 2465736?><pub-id pub-id-type="pmid">2465736</pub-id></element-citation></ref><ref id="CR15_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brinkworth</surname><given-names>RI</given-names></name><name><surname>Stoermer</surname><given-names>MJ</given-names></name><name><surname>Fairlie</surname><given-names>DP</given-names></name></person-group><article-title>Flavones are inhibitors of HIV-1 proteinase</article-title><source>Biochem Biophys Res Commun</source><year>1992</year><volume>188</volume><fpage>631</fpage><lpage>637</lpage><?supplied-pmid 1445308?><pub-id pub-id-type="pmid">1445308</pub-id></element-citation></ref><ref id="CR20_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cella</surname><given-names>M</given-names></name><name><surname>Riva</surname><given-names>DA</given-names></name><name><surname>Coulombi&#x000e9;</surname><given-names>FC</given-names></name><etal/></person-group><article-title>Virucidal activity presence in <italic>Trichilia glabra</italic> leaves</article-title><source>Rev Argent Microbiol</source><year>2004</year><volume>36</volume><fpage>136</fpage><lpage>138</lpage><?supplied-pmid 15559196?><pub-id pub-id-type="pmid">15559196</pub-id></element-citation></ref><ref id="CR22_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>JS</given-names></name><name><surname>Liu</surname><given-names>HW</given-names></name><name><surname>Wang</surname><given-names>KC</given-names></name><etal/></person-group><article-title>Ethanol extract of <italic>Polygonum cuspidatum</italic> inhibits hepatitis B virus in a stable HBV-producing cell line</article-title><source>Antiviral Res</source><year>2005</year><volume>66</volume><fpage>29</fpage><lpage>34</lpage><?supplied-pmid 15781129?><pub-id pub-id-type="pmid">15781129</pub-id></element-citation></ref><ref id="CR23_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chantrill</surname><given-names>BH</given-names></name><name><surname>Coulthard</surname><given-names>CE</given-names></name><name><surname>Dickinson</surname><given-names>L</given-names></name><etal/></person-group><article-title>The action of plant extracts on a bacteriophage of <italic>Pseudomonas pyocyanea</italic> and on influenza A virus</article-title><source>J Gen Microbiol</source><year>1952</year><volume>6</volume><fpage>74</fpage><lpage>84</lpage><?supplied-pmid 14927853?><pub-id pub-id-type="pmid">14927853</pub-id></element-citation></ref><ref id="CR24_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>D</given-names></name><name><surname>Chakraborty</surname><given-names>MS</given-names></name><name><surname>Saha</surname><given-names>GC</given-names></name></person-group><article-title>Viruses, the acellular parasites of cellular hosts: biology and pathology with special reference to HIV</article-title><source>Indian J STD AIDS</source><year>1999</year><volume>20</volume><fpage>54</fpage><lpage>60</lpage></element-citation></ref><ref id="CR25_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>D</given-names></name><name><surname>Arunachalam</surname><given-names>G</given-names></name><name><surname>Mandal</surname><given-names>AB</given-names></name><etal/></person-group><article-title>Dose-dependent therapeutic antiinfectives from ethnomedicines of bay islands</article-title><source>Chemotherapy</source><year>2006</year><volume>52</volume><fpage>151</fpage><lpage>157</lpage><?supplied-pmid 16636538?><pub-id pub-id-type="pmid">16636538</pub-id></element-citation></ref><ref id="CR26_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>K</given-names></name><name><surname>Mateu</surname><given-names>CG</given-names></name><name><surname>Mandal</surname><given-names>P</given-names></name><etal/></person-group><article-title>Galactan sulfate of <italic>Grateloupia indica</italic>: isolation, structural features and antiviral activity</article-title><source>Phytochemistry</source><year>2007</year><volume>68</volume><fpage>1428</fpage><lpage>1435</lpage><?supplied-pmid 17451760?><pub-id pub-id-type="pmid">17451760</pub-id></element-citation></ref><ref id="CR27_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>D</given-names></name><name><surname>Sarkar</surname><given-names>MC</given-names></name><name><surname>Chatterjee</surname><given-names>T</given-names></name><etal/></person-group><article-title>Recent advancements for the evaluation of anti-viral activities of natural products</article-title><source>N Biotechnol</source><year>2009</year><volume>25</volume><fpage>347</fpage><lpage>368</lpage><?supplied-pmid 19464980?><pub-id pub-id-type="pmid">19464980</pub-id></element-citation></ref><ref id="CR29_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>LC</given-names></name><name><surname>Chiang</surname><given-names>W</given-names></name><name><surname>Chang</surname><given-names>MY</given-names></name><etal/></person-group><article-title>Antiviral activity of <italic>Plantago major</italic> extracts and related compounds in vitro</article-title><source>Antiviral Res</source><year>2002</year><volume>55</volume><fpage>53</fpage><lpage>62</lpage><?supplied-pmid 12076751?><pub-id pub-id-type="pmid">12076751</pub-id></element-citation></ref><ref id="CR30_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>LC</given-names></name><name><surname>Chiang</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>MC</given-names></name><etal/></person-group><article-title><italic>In vitro</italic> antiviral activities of <italic>Caesalpinia pulcherrima</italic> and its related flavonoids</article-title><source>J Antimicrob Chemother</source><year>2003</year><volume>52</volume><fpage>194</fpage><lpage>198</lpage><?supplied-pmid 12837746?><pub-id pub-id-type="pmid">12837746</pub-id></element-citation></ref><ref id="CR31_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>LC</given-names></name><name><surname>Ng</surname><given-names>LT</given-names></name><name><surname>Chiang</surname><given-names>W</given-names></name></person-group><article-title>Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species</article-title><source>Planta Med</source><year>2003</year><volume>69</volume><fpage>600</fpage><lpage>604</lpage><?supplied-pmid 12898413?><pub-id pub-id-type="pmid">12898413</pub-id></element-citation></ref><ref id="CR32_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>HJ</given-names></name><name><surname>Lim</surname><given-names>CH</given-names></name><name><surname>Song</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Antiviral activity of raoulic acid from <italic>Raoulia australis</italic> against picornaviruses</article-title><source>Phytomedicine</source><year>2009</year><volume>16</volume><fpage>35</fpage><lpage>39</lpage><?supplied-pmid 19097770?><pub-id pub-id-type="pmid">19097770</pub-id></element-citation></ref><ref id="CR33_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>HJ</given-names></name><name><surname>Song</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication</article-title><source>Eur J Pharm Sci</source><year>2009</year><volume>37</volume><fpage>329</fpage><lpage>333</lpage><?supplied-pmid 19491023?><pub-id pub-id-type="pmid">19491023</pub-id></element-citation></ref><ref id="CR35_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>MI</given-names></name><name><surname>Benencia</surname><given-names>F</given-names></name><name><surname>Coulombie</surname><given-names>FC</given-names></name></person-group><article-title>Antiviral activity of an acidic polysaccharides fraction extracted from <italic>Cedrela tubiflora</italic> leaves</article-title><source>Fitoterapia</source><year>2001</year><volume>72</volume><fpage>113</fpage><lpage>119</lpage><?supplied-pmid 11223219?><pub-id pub-id-type="pmid">11223219</pub-id></element-citation></ref><ref id="CR37_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>JR</given-names></name><name><surname>Hallock</surname><given-names>YF</given-names></name><name><surname>Cardellina</surname><given-names>JH</given-names><suffix>2nd</suffix></name><name><surname>Boyd</surname><given-names>MR</given-names></name></person-group><article-title>HIV-inhibitory and cytotoxic oligostilbenes from the leaves of <italic>Hopea malibato</italic></article-title><source>J Nat Prod</source><year>1998</year><volume>61</volume><fpage>351</fpage><lpage>353</lpage><?supplied-pmid 9544565?><pub-id pub-id-type="pmid">9544565</pub-id></element-citation></ref><ref id="CR38_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damonte</surname><given-names>E</given-names></name><name><surname>Neyts</surname><given-names>J</given-names></name><name><surname>Pujol</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Antiviral activity of a sulphated polysaccharide from the red seaweed <italic>Nothogenia fastigiata</italic></article-title><source>Biochem Pharmacol</source><year>1994</year><volume>47</volume><fpage>2187</fpage><lpage>2192</lpage><?supplied-pmid 8031312?><pub-id pub-id-type="pmid">8031312</pub-id></element-citation></ref><ref id="CR39_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dangoria</surname><given-names>NS</given-names></name><name><surname>Breau</surname><given-names>WC</given-names></name><name><surname>Anderson</surname><given-names>HA</given-names></name><etal/></person-group><article-title>Extracellular simian virus 40 induces an ERK/MAP kinase-independent signalling pathway that activates primary response genes and promotes virus entry</article-title><source>J Gen Virol</source><year>1996</year><volume>77</volume><fpage>2173</fpage><lpage>2182</lpage><?supplied-pmid 8811017?><pub-id pub-id-type="pmid">8811017</pub-id></element-citation></ref><ref id="CR40_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Logu</surname><given-names>A</given-names></name><name><surname>Loy</surname><given-names>G</given-names></name><name><surname>Pellerano</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by <italic>Santolina insularis</italic> essential oil</article-title><source>Antiviral Res</source><year>2000</year><volume>48</volume><fpage>177</fpage><lpage>185</lpage><?supplied-pmid 11164504?><pub-id pub-id-type="pmid">11164504</pub-id></element-citation></ref><ref id="CR41_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debiaggi</surname><given-names>M</given-names></name><name><surname>Pagani</surname><given-names>L</given-names></name><name><surname>Cereda</surname><given-names>PM</given-names></name><etal/></person-group><article-title>Antiviral activity of <italic>Chamaecyparis lawsoniana</italic> extract: study with herpes simplex virus type 2</article-title><source>Microbiologica</source><year>1988</year><volume>11</volume><fpage>55</fpage><lpage>61</lpage><?supplied-pmid 2832710?><pub-id pub-id-type="pmid">2832710</pub-id></element-citation></ref><ref id="CR42_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demeule</surname><given-names>M</given-names></name><name><surname>Michaud-Levesque</surname><given-names>J</given-names></name><name><surname>Annabi</surname><given-names>B</given-names></name><etal/></person-group><article-title>Green tea catechins as novel antitumor and antiangiogenic compounds</article-title><source>Curr Med Chem Anticancer Agents</source><year>2002</year><volume>2</volume><fpage>441</fpage><lpage>463</lpage><?supplied-pmid 12678730?><pub-id pub-id-type="pmid">12678730</pub-id></element-citation></ref><ref id="CR44_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Docherty</surname><given-names>JJ</given-names></name><name><surname>Smith</surname><given-names>JS</given-names></name><name><surname>Fu</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice</article-title><source>Antiviral Res</source><year>2004</year><volume>61</volume><fpage>19</fpage><lpage>26</lpage><?supplied-pmid 14670590?><pub-id pub-id-type="pmid">14670590</pub-id></element-citation></ref><ref id="CR45_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Docherty</surname><given-names>JJ</given-names></name><name><surname>Fu</surname><given-names>MM</given-names></name><name><surname>Hah</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Effect of resveratrol on herpes simplex virus vaginal infection in the mouse</article-title><source>Antiviral Res</source><year>2005</year><volume>67</volume><fpage>155</fpage><lpage>162</lpage><?supplied-pmid 16125258?><pub-id pub-id-type="pmid">16125258</pub-id></element-citation></ref><ref id="CR46_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Docherty</surname><given-names>JJ</given-names></name><name><surname>Sweet</surname><given-names>TJ</given-names></name><name><surname>Bailey</surname><given-names>E</given-names></name><etal/></person-group><article-title>Resveratrol inhibition of varicella-zoster virus replication in vitro</article-title><source>Antiviral Res</source><year>2006</year><volume>72</volume><fpage>171</fpage><lpage>177</lpage><?supplied-pmid 16899306?><pub-id pub-id-type="pmid">16899306</pub-id></element-citation></ref><ref id="CR47_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duarte</surname><given-names>ME</given-names></name><name><surname>Noseda</surname><given-names>DG</given-names></name><name><surname>Noseda</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Inhibitory effect of sulfated galactans from the marine alga <italic>Bostrychia montagnei</italic> on herpes simplex virus replication in vitro</article-title><source>Phytomedicine</source><year>2001</year><volume>8</volume><fpage>53</fpage><lpage>58</lpage><?supplied-pmid 11292240?><pub-id pub-id-type="pmid">11292240</pub-id></element-citation></ref><ref id="CR48_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eo</surname><given-names>SK</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Lee</surname><given-names>CK</given-names></name><etal/></person-group><article-title>Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from <italic>Ganoderma lucidum</italic> on herpes simplex viruses</article-title><source>J Ethnopharmacol</source><year>2000</year><volume>72</volume><fpage>475</fpage><lpage>481</lpage><?supplied-pmid 10996289?><pub-id pub-id-type="pmid">10996289</pub-id></element-citation></ref><ref id="CR50_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evers</surname><given-names>DL</given-names></name><name><surname>Chao</surname><given-names>CF</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action</article-title><source>Antiviral Res</source><year>2005</year><volume>68</volume><fpage>124</fpage><lpage>134</lpage><?supplied-pmid 16188329?><pub-id pub-id-type="pmid">16188329</pub-id></element-citation></ref><ref id="CR51_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felipe</surname><given-names>AM</given-names></name><name><surname>Rinc&#x000e3;o</surname><given-names>VP</given-names></name><name><surname>Benati</surname><given-names>FJ</given-names></name><etal/></person-group><article-title>Antiviral effect of <italic>Guazuma ulmifolia</italic> and Stryphnodendron adstringens on poliovirus and bovine herpesvirus</article-title><source>Biol Pharm Bull</source><year>2006</year><volume>29</volume><fpage>1092</fpage><lpage>1095</lpage><?supplied-pmid 16754999?><pub-id pub-id-type="pmid">16754999</pub-id></element-citation></ref><ref id="CR53_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritz</surname><given-names>D</given-names></name><name><surname>Venturi</surname><given-names>CR</given-names></name><name><surname>Cargnin</surname><given-names>S</given-names></name><etal/></person-group><article-title>Herpes virus inhibitory substances from <italic>Hypericum connatum</italic> Lam., a plant used in southern Brazil to treat oral lesions</article-title><source>J Ethnopharmacol</source><year>2007</year><volume>113</volume><fpage>517</fpage><lpage>520</lpage><?supplied-pmid 17719731?><pub-id pub-id-type="pmid">17719731</pub-id></element-citation></ref><ref id="CR54_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>M</given-names></name><name><surname>Longnecker</surname><given-names>R</given-names></name></person-group><article-title>Epstein&#x02013;Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>8655</fpage><lpage>8660</lpage><?supplied-pmid 15956608?><pub-id pub-id-type="pmid">15956608</pub-id></element-citation></ref><ref id="CR55_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusco</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Savage</surname><given-names>C</given-names></name><etal/></person-group><article-title><italic>Echinacea purpurea</italic> aerial extract alters course of influenza infection in mice</article-title><source>Vaccine</source><year>2010</year><volume>28</volume><fpage>3956</fpage><lpage>3962</lpage><?supplied-pmid 20382242?><pub-id pub-id-type="pmid">20382242</pub-id></element-citation></ref><ref id="CR57_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>G</given-names></name><name><surname>Cavallaro</surname><given-names>L</given-names></name><name><surname>Broussalis</surname><given-names>A</given-names></name><etal/></person-group><article-title>Biological and chemical characterization of the fraction with antiherpetic activity from <italic>Achyrocline flaccida</italic></article-title><source>Planta Med</source><year>1999</year><volume>65</volume><fpage>343</fpage><lpage>346</lpage><?supplied-pmid 10364841?><pub-id pub-id-type="pmid">10364841</pub-id></element-citation></ref><ref id="CR01_3"><mixed-citation publication-type="other">Golan DE, Tashjian Jr AH, Armstrong EJ et al (2009) Principles of pharmacology: the patho&#x000ad;physiologic basis of drug therapy. Wolters Kluwer Health/Lippincott Williams &#x00026; Wilkins, Philadelphia</mixed-citation></ref><ref id="CR60_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greiner</surname><given-names>LL</given-names></name><name><surname>Stahly</surname><given-names>TS</given-names></name><name><surname>Stabel</surname><given-names>TJ</given-names></name></person-group><article-title>The effect of dietary soy genistein on pig growth and viral replication during a viral challenge</article-title><source>J Anim Sci</source><year>2001</year><volume>79</volume><fpage>1272</fpage><lpage>1279</lpage><?supplied-pmid 11374547?><pub-id pub-id-type="pmid">11374547</pub-id></element-citation></ref><ref id="CR63_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Otsuka</surname><given-names>H</given-names></name><etal/></person-group><article-title>Antiviral activity of 5,6,7- trimethoxyflavone and its potentiation of the antiherpes activity of acyclovir</article-title><source>J Antimicrob Chemother</source><year>1997</year><volume>39</volume><fpage>821</fpage><lpage>824</lpage><?supplied-pmid 9222055?><pub-id pub-id-type="pmid">9222055</pub-id></element-citation></ref><ref id="CR65_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herold</surname><given-names>BC</given-names></name><name><surname>Gerber</surname><given-names>SI</given-names></name><name><surname>Polonsky</surname><given-names>T</given-names></name><etal/></person-group><article-title>Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding</article-title><source>Virology</source><year>1995</year><volume>206</volume><fpage>1108</fpage><lpage>1116</lpage><?supplied-pmid 7856085?><pub-id pub-id-type="pmid">7856085</pub-id></element-citation></ref><ref id="CR67_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>RL</given-names></name><name><surname>Huang</surname><given-names>YL</given-names></name><name><surname>Ou</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Screening of 25 compounds isolated from Phyllanthus species for anti-human hepatitis B virus in vitro</article-title><source>Phytother Res</source><year>2003</year><volume>17</volume><fpage>449</fpage><lpage>453</lpage><?supplied-pmid 12748977?><pub-id pub-id-type="pmid">12748977</pub-id></element-citation></ref><ref id="CR68_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>KL</given-names></name><name><surname>Lai</surname><given-names>YK</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name></person-group><article-title>Inhibition of hepatitis B virus production by <italic>Boehmeria nivea</italic> root extract in HepG2 2.2.15 cells</article-title><source>World J Gastroenterol</source><year>2006</year><volume>12</volume><fpage>5721</fpage><lpage>5725</lpage><?supplied-pmid 17007029?><pub-id pub-id-type="pmid">17007029</pub-id></element-citation></ref><ref id="CR70_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huheihel</surname><given-names>M</given-names></name><name><surname>Ishanu</surname><given-names>V</given-names></name><name><surname>Tal</surname><given-names>J</given-names></name><etal/></person-group><article-title>Activity of <italic>Porphyridium sp</italic> polysaccharide against herpes simplex viruses in vitro and in vivo</article-title><source>J Biochem Biophys Methods</source><year>2002</year><volume>50</volume><fpage>189</fpage><lpage>200</lpage><?supplied-pmid 11741707?><pub-id pub-id-type="pmid">11741707</pub-id></element-citation></ref><ref id="CR71_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaacs</surname><given-names>CE</given-names></name><name><surname>Wen</surname><given-names>GY</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><etal/></person-group><article-title>Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus</article-title><source>Antimicrob Agents Chemother</source><year>2008</year><volume>52</volume><fpage>962</fpage><lpage>970</lpage><?supplied-pmid 18195068?><pub-id pub-id-type="pmid">18195068</pub-id></element-citation></ref><ref id="CR74_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jassim</surname><given-names>SA</given-names></name><name><surname>Naji</surname><given-names>MA</given-names></name></person-group><article-title>Novel antiviral agents: a medicinal plant perspective</article-title><source>J Appl Microbiol</source><year>2003</year><volume>95</volume><fpage>412</fpage><lpage>427</lpage><?supplied-pmid 12911688?><pub-id pub-id-type="pmid">12911688</pub-id></element-citation></ref><ref id="CR75_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javed</surname><given-names>T</given-names></name><name><surname>Ashfaq</surname><given-names>UA</given-names></name><name><surname>Riaz</surname><given-names>S</given-names></name><etal/></person-group><article-title>In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus</article-title><source>Virol J</source><year>2011</year><volume>8</volume><fpage>26</fpage><?supplied-pmid 21247464?><pub-id pub-id-type="pmid">21247464</pub-id></element-citation></ref><ref id="CR76_3"><mixed-citation publication-type="other">Jiang ZR (2005) Chinese economic pillars of dialysis UK &#x02013; UK survey development of Chinese medicine. Overseas review no. 4, pp 201&#x02013;202</mixed-citation></ref><ref id="CR78_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>RW</given-names></name><name><surname>Ma</surname><given-names>SC</given-names></name><name><surname>He</surname><given-names>ZD</given-names></name><etal/></person-group><article-title>Molecular structures and antiviral activities of naturally occurring and modified cassane furanoditerpenoids and friedelane triterpenoids from <italic>Caesalpinia minax</italic></article-title><source>Bioorg Med Chem</source><year>2002</year><volume>10</volume><fpage>2161</fpage><lpage>2170</lpage><?supplied-pmid 11983512?><pub-id pub-id-type="pmid">11983512</pub-id></element-citation></ref><ref id="CR81_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karmakar</surname><given-names>P</given-names></name><name><surname>Pujol</surname><given-names>CA</given-names></name><name><surname>Damonte</surname><given-names>EB</given-names></name><etal/></person-group><article-title>Polysaccharides from <italic>Padina tetrastromatica:</italic> structure features, chemical modification and antiviral activity</article-title><source>Carbohydr Polym</source><year>2010</year><volume>80</volume><fpage>513</fpage><lpage>520</lpage></element-citation></ref><ref id="CR84_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Hyun</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Irisolidone, an isoflavone metabolite, represses JC virus gene expression via inhibition of Sp1 binding in human glial cells</article-title><source>Biochem Biophys Res Commun</source><year>2006</year><volume>344</volume><fpage>3</fpage><lpage>8</lpage><?supplied-pmid 16630573?><pub-id pub-id-type="pmid">16630573</pub-id></element-citation></ref><ref id="CR85_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>C</given-names></name><name><surname>Reichling</surname><given-names>J</given-names></name><name><surname>Schneele</surname><given-names>J</given-names></name><etal/></person-group><article-title>Inhibitory effect of essential oils against herpes simplex virus type 2</article-title><source>Phytomedicine</source><year>2008</year><volume>15</volume><fpage>71</fpage><lpage>78</lpage><?supplied-pmid 17976968?><pub-id pub-id-type="pmid">17976968</pub-id></element-citation></ref><ref id="CR86_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konowalchuk</surname><given-names>J</given-names></name><name><surname>Speirs</surname><given-names>JI</given-names></name></person-group><article-title>Virus inactivation by grapes and wines</article-title><source>Appl Environ Microbiol</source><year>1976</year><volume>32</volume><fpage>757</fpage><lpage>763</lpage><?supplied-pmid 12719?><pub-id pub-id-type="pmid">12719</pub-id></element-citation></ref><ref id="CR87_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konowalchuk</surname><given-names>J</given-names></name><name><surname>Speirs</surname><given-names>JI</given-names></name></person-group><article-title>Antiviral effect of apple beverages</article-title><source>Appl Environ Microbiol</source><year>1978</year><volume>36</volume><fpage>798</fpage><lpage>801</lpage><?supplied-pmid 32832?><pub-id pub-id-type="pmid">32832</pub-id></element-citation></ref><ref id="CR88_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konowalchuk</surname><given-names>J</given-names></name><name><surname>Speirs</surname><given-names>JI</given-names></name></person-group><article-title>Antiviral effect of commercial juices and beverages</article-title><source>Appl Environ Microbiol</source><year>1978</year><volume>35</volume><issue>6</issue><fpage>1219</fpage><lpage>1220</lpage><?supplied-pmid 209736?><pub-id pub-id-type="pmid">209736</pub-id></element-citation></ref><ref id="CR89_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotwal</surname><given-names>GJ</given-names></name><name><surname>Kaczmarek</surname><given-names>JN</given-names></name><name><surname>Leivers</surname><given-names>S</given-names></name></person-group><article-title>Anti-HIV, anti-poxvirus, and anti-SARS activity of a nontoxic, acidic plant extract from the Trifollium species Secomet-V/anti-vac suggests that it contains a novel broad-spectrum antiviral</article-title><source>Ann N Y Acad Sci</source><year>2005</year><volume>1056</volume><fpage>293</fpage><lpage>302</lpage><?supplied-pmid 16387696?><pub-id pub-id-type="pmid">16387696</pub-id></element-citation></ref><ref id="CR90_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubo</surname><given-names>Y</given-names></name><name><surname>Ishimoto</surname><given-names>A</given-names></name><name><surname>Amanuma</surname><given-names>H</given-names></name></person-group><article-title>Genistein, a protein tyrosine kinase inhibitor, suppresses the fusogenicity of Moloney murine leukemia virus envelope protein in XC cells</article-title><source>Arch Virol</source><year>2003</year><volume>148</volume><fpage>1899</fpage><lpage>1914</lpage><?supplied-pmid 14551814?><pub-id pub-id-type="pmid">14551814</pub-id></element-citation></ref><ref id="CR95_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>DH</given-names></name><name><surname>Kwon</surname><given-names>HY</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Inhibition of hepatitis B virus by an aqueous extract of <italic>Agrimonia eupatoria</italic> L</article-title><source>Phytother Res</source><year>2005</year><volume>19</volume><fpage>355</fpage><lpage>358</lpage><?supplied-pmid 16041735?><pub-id pub-id-type="pmid">16041735</pub-id></element-citation></ref><ref id="CR96_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lecot</surname><given-names>S</given-names></name><name><surname>Belouzard</surname><given-names>S</given-names></name><name><surname>Dubuisson</surname><given-names>J</given-names></name><etal/></person-group><article-title>Bovine viral diarrhea virus entry is dependent on clathrin-mediated endocytosis</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>10826</fpage><lpage>10829</lpage><?supplied-pmid 16051874?><pub-id pub-id-type="pmid">16051874</pub-id></element-citation></ref><ref id="CR97_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee-Huang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>PL</given-names></name><etal/></person-group><article-title>Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment</article-title><source>Biochem Biophys Res Commun</source><year>2003</year><volume>307</volume><fpage>1029</fpage><lpage>1037</lpage><?supplied-pmid 12878215?><pub-id pub-id-type="pmid">12878215</pub-id></element-citation></ref><ref id="CR04_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lestienne</surname><given-names>P</given-names></name><name><surname>Pourquier</surname><given-names>P</given-names></name><name><surname>Bonnet</surname><given-names>J</given-names></name></person-group><article-title>Elongation of oligonucleotide primers forming a triple helix on double-stranded DNA templates by purified DNA polymerases</article-title><source>Biochem Biophys Res Commun</source><year>2003</year><volume>311</volume><fpage>380</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">14592425</pub-id></element-citation></ref><ref id="CR98_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>JW</given-names></name><name><surname>Vederas</surname><given-names>JC</given-names></name></person-group><article-title>Drug discovery and natural products: end of an era or an endless frontier?</article-title><source>Science</source><year>2009</year><volume>325</volume><fpage>161</fpage><lpage>165</lpage><?supplied-pmid 19589993?><pub-id pub-id-type="pmid">19589993</pub-id></element-citation></ref><ref id="CR100_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>BQ</given-names></name><name><surname>Fu</surname><given-names>T</given-names></name><name><surname>Dongyan</surname><given-names>Y</given-names></name><name><surname>Mikovits</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry</article-title><source>Biochem Biophys Res Commun</source><year>2000</year><volume>276</volume><fpage>534</fpage><lpage>538</lpage><?supplied-pmid 11027509?><pub-id pub-id-type="pmid">11027509</pub-id></element-citation></ref><ref id="CR101_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>E</given-names></name><name><surname>Stupack</surname><given-names>DG</given-names></name><name><surname>Brown</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Association of p130CAS with hosphatidylinositol-3-OH kinase mediates adenovirus cell entry</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>14729</fpage><lpage>14735</lpage><?supplied-pmid 10799562?><pub-id pub-id-type="pmid">10799562</pub-id></element-citation></ref><ref id="CR102_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>SY</given-names></name><name><surname>Wu</surname><given-names>MD</given-names></name><name><surname>Wang</surname><given-names>CW</given-names></name><etal/></person-group><article-title>A novel anti-HBeAg homolignan, taiwanschirin D from <italic>Kadsura matsudai</italic></article-title><source>Chem Pharm Bull(Tokyo)</source><year>2000</year><volume>48</volume><fpage>1992</fpage><lpage>1993</lpage><pub-id pub-id-type="pmid">11215493</pub-id></element-citation></ref><ref id="CR103_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YL</given-names></name><name><surname>Ma</surname><given-names>SC</given-names></name><name><surname>Yang</surname><given-names>YT</given-names></name><etal/></person-group><article-title>Antiviral activities of flavonoids and organic acid from <italic>Trollius chinensis</italic> Bunge</article-title><source>J Ethnopharmacol</source><year>2002</year><volume>79</volume><fpage>365</fpage><lpage>368</lpage><?supplied-pmid 11849843?><pub-id pub-id-type="pmid">11849843</pub-id></element-citation></ref><ref id="CR104_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>SY</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>HQ</given-names></name><etal/></person-group><article-title>Identification of natural compounds with antiviral activities against SARS-associated coronavirus</article-title><source>Antiviral Res</source><year>2005</year><volume>67</volume><fpage>18</fpage><lpage>23</lpage><?supplied-pmid 15885816?><pub-id pub-id-type="pmid">15885816</pub-id></element-citation></ref><ref id="CR105_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>But</surname><given-names>PP</given-names></name><name><surname>Ooi</surname><given-names>VE</given-names></name></person-group><article-title>Antiviral activity and mode of action of caffeoylquinic acids from <italic>Schefflera heptaphylla</italic> (L.) Frodin</article-title><source>Antiviral Res</source><year>2005</year><volume>68</volume><fpage>1</fpage><lpage>9</lpage><?supplied-pmid 16140400?><pub-id pub-id-type="pmid">16140400</pub-id></element-citation></ref><ref id="CR109_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Ye</surname><given-names>LB</given-names></name><etal/></person-group><article-title>Possible mode of action of antiherpetic activities of a proteoglycan isolated from the mycelia of <italic>Ganoderma lucidum</italic> in vitro</article-title><source>J Ethnopharmacol</source><year>2004</year><volume>95</volume><fpage>265</fpage><lpage>272</lpage><?supplied-pmid 15507347?><pub-id pub-id-type="pmid">15507347</pub-id></element-citation></ref><ref id="CR110_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>AL</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Qin</surname><given-names>HL</given-names></name><etal/></person-group><article-title>Anti-influenza virus activities of flavonoids from the medicinal plant <italic>Elsholtzia rugulosa</italic></article-title><source>Planta Med</source><year>2008</year><volume>74</volume><fpage>746</fpage><lpage>751</lpage></element-citation></ref><ref id="CR111_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>AL</given-names></name><name><surname>Wang</surname><given-names>HD</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities</article-title><source>Bioorg Med Chem</source><year>2008</year><volume>16</volume><fpage>7141</fpage><lpage>7147</lpage><?supplied-pmid 18640042?><pub-id pub-id-type="pmid">18640042</pub-id></element-citation></ref><ref id="CR112_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>AL</given-names></name><name><surname>Shu</surname><given-names>SH</given-names></name><name><surname>Qin</surname><given-names>HL</given-names></name><etal/></person-group><article-title>In vitro anti-influenza viral activities of constituents from <italic>Caesalpinia sappan</italic></article-title><source>Planta Med</source><year>2009</year><volume>75</volume><fpage>337</fpage><lpage>339</lpage><?supplied-pmid 19148862?><pub-id pub-id-type="pmid">19148862</pub-id></element-citation></ref><ref id="CR113_3"><mixed-citation publication-type="other">Liu AL, Yang F, Zu M et al (2010) <italic>In vitro</italic> anti-influenza viral activities of stilbenoids from the lianas of <italic>Gnetum pendulum</italic>. Planta Med. doi:10.1055/s-0030-1250030</mixed-citation></ref><ref id="CR114_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loizzo</surname><given-names>MR</given-names></name><name><surname>Saab</surname><given-names>A</given-names></name><name><surname>Tundis</surname><given-names>R</given-names></name><etal/></person-group><article-title>Phytochemical analysis and in vitro evaluation of the biological activity against herpes simplex virus type 1 (HSV-1) of Cedrus libani A. Rich</article-title><source>Phytomedicine</source><year>2008</year><volume>15</volume><fpage>79</fpage><lpage>83</lpage><?supplied-pmid 17482448?><pub-id pub-id-type="pmid">17482448</pub-id></element-citation></ref><ref id="CR02_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>DO</given-names></name><name><surname>Regis-da-Silva</surname><given-names>CG</given-names></name><name><surname>Machado-Silva</surname><given-names>A</given-names></name><etal/></person-group><article-title>Analysis of DNA polymerase activity in vitro using non-radioactive primer extension assay in an automated DNA sequencer</article-title><source>Genet Mol Res</source><year>2007</year><volume>6</volume><fpage>250</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">17573654</pub-id></element-citation></ref><ref id="CR115_3"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lou</surname><given-names>SD</given-names></name></person-group><source>Research on anti-HIV activities of Chinese herbal medicines</source><year>1998</year><publisher-loc>Kunming</publisher-loc><publisher-name>Yunnan Science and Technology</publisher-name></element-citation></ref><ref id="CR116_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyu</surname><given-names>SY</given-names></name><name><surname>Rhim</surname><given-names>JY</given-names></name><name><surname>Park</surname><given-names>WB</given-names></name></person-group><article-title>Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro</article-title><source>Arch Pharm Res</source><year>2005</year><volume>28</volume><fpage>1293</fpage><lpage>1301</lpage><?supplied-pmid 16350858?><pub-id pub-id-type="pmid">16350858</pub-id></element-citation></ref><ref id="CR119_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchetti</surname><given-names>M</given-names></name><name><surname>Pisani</surname><given-names>S</given-names></name><name><surname>Pietropaolo</surname><given-names>V</given-names></name><etal/></person-group><article-title>Antiviral effect of a polysaccharide from <italic>Sclerotium glucanicum</italic> towards herpes simplex virus type 1 infection</article-title><source>Planta Med</source><year>1996</year><volume>62</volume><fpage>303</fpage><lpage>307</lpage><?supplied-pmid 8792659?><pub-id pub-id-type="pmid">8792659</pub-id></element-citation></ref><ref id="CR120_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>MJ</given-names></name><name><surname>Olmo</surname><given-names>LM</given-names></name><name><surname>Benito</surname><given-names>PB</given-names></name></person-group><article-title>Antiviral activities of polysaccharides from natural sources</article-title><source>Stud Nat Prod Chem</source><year>2005</year><volume>30</volume><fpage>393</fpage><lpage>418</lpage></element-citation></ref><ref id="CR122_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCutcheon</surname><given-names>AR</given-names></name><name><surname>Roberts</surname><given-names>TE</given-names></name><name><surname>Gibbons</surname><given-names>E</given-names></name><etal/></person-group><article-title>Antiviral screening of British Columbian medicinal plants</article-title><source>J Ethnopharmacol</source><year>1995</year><volume>49</volume><fpage>101</fpage><lpage>110</lpage><?supplied-pmid 8847882?><pub-id pub-id-type="pmid">8847882</pub-id></element-citation></ref><ref id="CR126_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Micol</surname><given-names>V</given-names></name><name><surname>Caturla</surname><given-names>N</given-names></name><name><surname>P&#x000e9;rez-Fons</surname><given-names>L</given-names></name><etal/></person-group><article-title>The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV)</article-title><source>Antiviral Res</source><year>2005</year><volume>66</volume><fpage>129</fpage><lpage>136</lpage><?supplied-pmid 15869811?><pub-id pub-id-type="pmid">15869811</pub-id></element-citation></ref><ref id="CR127_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miki</surname><given-names>K</given-names></name><name><surname>Nagai</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><etal/></person-group><article-title>Anti-influenza virus activity of biflavonoids</article-title><source>Bioorg Med Chem Lett</source><year>2007</year><volume>17</volume><fpage>772</fpage><lpage>775</lpage><?supplied-pmid 17110111?><pub-id pub-id-type="pmid">17110111</pub-id></element-citation></ref><ref id="CR128_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukhtar</surname><given-names>M</given-names></name><name><surname>Arshad</surname><given-names>M</given-names></name><name><surname>Ahmad</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antiviral potential of medicinal plants</article-title><source>Virus Res</source><year>2008</year><volume>131</volume><fpage>111</fpage><lpage>120</lpage><?supplied-pmid 17981353?><pub-id pub-id-type="pmid">17981353</pub-id></element-citation></ref><ref id="CR129_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>DJ</given-names></name><name><surname>Cragg</surname><given-names>GM</given-names></name></person-group><article-title>Natural products as sources of new drugs over the last 25 years</article-title><source>J Nat Prod</source><year>2007</year><volume>70</volume><fpage>461</fpage><lpage>477</lpage><?supplied-pmid 17309302?><pub-id pub-id-type="pmid">17309302</pub-id></element-citation></ref><ref id="CR131_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Notka</surname><given-names>F</given-names></name><name><surname>Meier</surname><given-names>G</given-names></name><name><surname>Wagner</surname><given-names>R</given-names></name><etal/></person-group><article-title>Concerted inhibitory activities of <italic>Phyllanthus amarus</italic> on HIV replication in vitro and ex vivo</article-title><source>Antiviral Res</source><year>2004</year><volume>64</volume><fpage>93</fpage><lpage>102</lpage><?supplied-pmid 15498604?><pub-id pub-id-type="pmid">15498604</pub-id></element-citation></ref><ref id="CR134_3"><mixed-citation publication-type="other">Orhan DD, Oz&#x000e7;elik B, Ozgen S et al (2009) Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiol Res. doi:10.1016/j.micres. 2009.09.002</mixed-citation></ref><ref id="CR135_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pantev</surname><given-names>A</given-names></name><name><surname>Ivancheva</surname><given-names>S</given-names></name><name><surname>Staneva</surname><given-names>L</given-names></name><etal/></person-group><article-title>Biologically active constituents of a polyphenol extract from <italic>Geranium sanguineum</italic> L. with anti-influenza activity</article-title><source>Z Naturforsch C</source><year>2006</year><volume>61</volume><fpage>508</fpage><lpage>516</lpage><?supplied-pmid 16989309?><pub-id pub-id-type="pmid">16989309</pub-id></element-citation></ref><ref id="CR136_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parida</surname><given-names>MM</given-names></name><name><surname>Upadhyay</surname><given-names>C</given-names></name><name><surname>Pandya</surname><given-names>G</given-names></name><etal/></person-group><article-title>Inhibitory potential of neem (Azadirachta indica Juss) leaves on dengue virus type-2 replication</article-title><source>J Ethnopharmacol</source><year>2002</year><volume>79</volume><fpage>273</fpage><lpage>278</lpage><?supplied-pmid 11801392?><pub-id pub-id-type="pmid">11801392</pub-id></element-citation></ref><ref id="CR137_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelkmans</surname><given-names>L</given-names></name><name><surname>Puntener</surname><given-names>D</given-names></name><name><surname>Helenius</surname><given-names>A</given-names></name></person-group><article-title>Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae</article-title><source>Science</source><year>2002</year><volume>296</volume><fpage>535</fpage><lpage>539</lpage><?supplied-pmid 11964480?><pub-id pub-id-type="pmid">11964480</pub-id></element-citation></ref><ref id="CR140_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Premanathan</surname><given-names>M</given-names></name><name><surname>Kathiresan</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>N</given-names></name><etal/></person-group><article-title>In vitro anti-human immunodeficiency virus activity of polysaccharide from <italic>Rhizophora mucronata</italic> Poir</article-title><source>Biosci Biotechnol Biochem</source><year>1999</year><volume>63</volume><fpage>1187</fpage><lpage>1191</lpage><?supplied-pmid 10478446?><pub-id pub-id-type="pmid">10478446</pub-id></element-citation></ref><ref id="CR141_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rechter</surname><given-names>S</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>T</given-names></name><name><surname>Auerochs</surname><given-names>S</given-names></name><etal/></person-group><article-title>Antiviral activity of Arthrospira-derived spirulan-like substances</article-title><source>Antiviral Res</source><year>2006</year><volume>72</volume><fpage>197</fpage><lpage>206</lpage><?supplied-pmid 16884788?><pub-id pub-id-type="pmid">16884788</pub-id></element-citation></ref><ref id="CR142_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehman</surname><given-names>S</given-names></name><name><surname>Ashfaq</surname><given-names>UA</given-names></name><name><surname>Riaz</surname><given-names>S</given-names></name><etal/></person-group><article-title>Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells</article-title><source>Virol J</source><year>2011</year><volume>8</volume><fpage>220</fpage><?supplied-pmid 21569385?><pub-id pub-id-type="pmid">21569385</pub-id></element-citation></ref><ref id="CR143_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reis</surname><given-names>SR</given-names></name><name><surname>Valente</surname><given-names>LM</given-names></name><name><surname>Sampaio</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Immunomodulating and antiviral activities of Uncaria tomentosa on human monocytes infected with Dengue Virus-2</article-title><source>Int Immunopharmacol</source><year>2008</year><volume>8</volume><fpage>468</fpage><lpage>476</lpage><?supplied-pmid 18279801?><pub-id pub-id-type="pmid">18279801</pub-id></element-citation></ref><ref id="CR144_3"><mixed-citation publication-type="other">Reuter J, W&#x000f6;lfle U, Weckesser S (2010) Which plant for which skin disease? Part 1: atopic dermatitis, psoriasis, acne, condyloma and herpes simplex. J Dtsch Dermatol Ges. doi:10.1111/j.1610-0387.2010.07496.x</mixed-citation></ref><ref id="CR146_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rixon</surname><given-names>HW</given-names></name><name><surname>Brown</surname><given-names>G</given-names></name><name><surname>Murray</surname><given-names>JT</given-names></name><etal/></person-group><article-title>The respiratory syncytial virus small hydrophobic protein is phosphorylated via a mitogenactivated protein kinase p38-dependent tyrosine kinase activity during virus infection</article-title><source>J Gen Virol</source><year>2005</year><volume>86</volume><fpage>375</fpage><lpage>384</lpage><?supplied-pmid 15659757?><pub-id pub-id-type="pmid">15659757</pub-id></element-citation></ref><ref id="CR147_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robin</surname><given-names>V</given-names></name><name><surname>Irurzun</surname><given-names>A</given-names></name><name><surname>Amoros</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antipoliovirus flavonoids from <italic>Psiadia dentata</italic></article-title><source>Antivir Chem Chemother</source><year>2001</year><volume>12</volume><fpage>283</fpage><lpage>291</lpage><?supplied-pmid 11900347?><pub-id pub-id-type="pmid">11900347</pub-id></element-citation></ref><ref id="CR148_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvati</surname><given-names>AL</given-names></name><name><surname>De Dominicis</surname><given-names>A</given-names></name><name><surname>Tait</surname><given-names>S</given-names></name><etal/></person-group><article-title>Mechanism of action at the molecular level of the antiviral drug 3(2H)- isoflavene against type 2 poliovirus</article-title><source>Antimicrob Agents Chemother</source><year>2004</year><volume>48</volume><fpage>2233</fpage><lpage>2243</lpage><?supplied-pmid 15155227?><pub-id pub-id-type="pmid">15155227</pub-id></element-citation></ref><ref id="CR150_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnitzler</surname><given-names>P</given-names></name><name><surname>Schuhmacher</surname><given-names>A</given-names></name><name><surname>Astani</surname><given-names>A</given-names></name><etal/></person-group><article-title><italic>Melissa officinalis</italic> oil affects infectivity of enveloped herpesviruses</article-title><source>Phytomedicine</source><year>2008</year><volume>15</volume><fpage>734</fpage><lpage>740</lpage><?supplied-pmid 18693101?><pub-id pub-id-type="pmid">18693101</pub-id></element-citation></ref><ref id="CR151_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuhmacher</surname><given-names>A</given-names></name><name><surname>Reichling</surname><given-names>J</given-names></name><name><surname>Schnitzler</surname><given-names>P</given-names></name></person-group><article-title>Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro</article-title><source>Phytomedicine</source><year>2003</year><volume>10</volume><fpage>504</fpage><lpage>510</lpage><?supplied-pmid 13678235?><pub-id pub-id-type="pmid">13678235</pub-id></element-citation></ref><ref id="CR152_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semple</surname><given-names>SJ</given-names></name><name><surname>Nobbs</surname><given-names>SF</given-names></name><name><surname>Pyke</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Antiviral flavonoid from <italic>Pterocaulon sphacelatum</italic>, an Australian Aboriginal medicine</article-title><source>J Ethnopharmacol</source><year>1999</year><volume>68</volume><fpage>283</fpage><lpage>288</lpage><?supplied-pmid 10624889?><pub-id pub-id-type="pmid">10624889</pub-id></element-citation></ref><ref id="CR153_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semple</surname><given-names>SJ</given-names></name><name><surname>Pyke</surname><given-names>SM</given-names></name><name><surname>Reynolds</surname><given-names>GD</given-names></name><etal/></person-group><article-title>In vitro antiviral activity of the anthraquinone chrysophanic acid against poliovirus</article-title><source>Antiviral Res</source><year>2001</year><volume>49</volume><fpage>169</fpage><lpage>178</lpage><?supplied-pmid 11428243?><pub-id pub-id-type="pmid">11428243</pub-id></element-citation></ref><ref id="CR155_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serkedjieva</surname><given-names>J</given-names></name></person-group><article-title>Antiinfective activity of a plant preparation from <italic>Geranium sanguineum</italic> L</article-title><source>Pharmazie</source><year>1997</year><volume>52</volume><fpage>799</fpage><lpage>802</lpage><?supplied-pmid 9362094?><pub-id pub-id-type="pmid">9362094</pub-id></element-citation></ref><ref id="CR156_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serkedjieva</surname><given-names>J</given-names></name></person-group><article-title>Influenza virus variants with reduced susceptibility to inhibition by a polyphenol extract from Geranium sanguineum L</article-title><source>Pharmazie</source><year>2003</year><volume>58</volume><fpage>53</fpage><lpage>57</lpage><?supplied-pmid 12622254?><pub-id pub-id-type="pmid">12622254</pub-id></element-citation></ref><ref id="CR157_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serkedjieva</surname><given-names>J</given-names></name><name><surname>Ivancheva</surname><given-names>S</given-names></name></person-group><article-title>Antiherpes virus activity of extracts from the medicinal plant <italic>Geranium sanguineum</italic> L</article-title><source>J Ethnopharmacol</source><year>1999</year><volume>64</volume><fpage>59</fpage><lpage>68</lpage><?supplied-pmid 10075123?><pub-id pub-id-type="pmid">10075123</pub-id></element-citation></ref><ref id="CR158_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma-Walia</surname><given-names>N</given-names></name><name><surname>Naranatt</surname><given-names>PP</given-names></name><name><surname>Krishnan</surname><given-names>HH</given-names></name><etal/></person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>4207</fpage><lpage>4223</lpage><?supplied-pmid 15047836?><pub-id pub-id-type="pmid">15047836</pub-id></element-citation></ref><ref id="CR163_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinico</surname><given-names>C</given-names></name><name><surname>De Logu</surname><given-names>A</given-names></name><name><surname>Lai</surname><given-names>F</given-names></name><etal/></person-group><article-title>Liposomal incorporation of <italic>Artemisia arborescens</italic> L. essential oil and in vitro antiviral activity</article-title><source>Eur J Pharm Biopharm</source><year>2005</year><volume>59</volume><fpage>161</fpage><lpage>168</lpage><?supplied-pmid 15567314?><pub-id pub-id-type="pmid">15567314</pub-id></element-citation></ref><ref id="CR164_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siow</surname><given-names>YL</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Au-Yeung</surname><given-names>KK</given-names></name></person-group><article-title>Emerging issues in traditional Chinese medicine</article-title><source>Can J Physiol Pharmacol</source><year>2005</year><volume>83</volume><fpage>321</fpage><lpage>334</lpage><?supplied-pmid 15877107?><pub-id pub-id-type="pmid">15877107</pub-id></element-citation></ref><ref id="CR165_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sivapalasingam</surname><given-names>S</given-names></name><name><surname>Essajee</surname><given-names>S</given-names></name><name><surname>Nyambi</surname><given-names>PN</given-names></name><etal/></person-group><article-title>Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: implications for resource-limited settings</article-title><source>J Clin Microbiol</source><year>2005</year><volume>43</volume><fpage>3793</fpage><lpage>3796</lpage><?supplied-pmid 16081912?><pub-id pub-id-type="pmid">16081912</pub-id></element-citation></ref><ref id="CR166_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Seong</surname><given-names>BL</given-names></name></person-group><article-title>Antiviral effect of catechins in green tea on influenza virus</article-title><source>Antiviral Res</source><year>2005</year><volume>68</volume><fpage>66</fpage><lpage>74</lpage><?supplied-pmid 16137775?><pub-id pub-id-type="pmid">16137775</pub-id></element-citation></ref><ref id="CR169_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stantchev</surname><given-names>TS</given-names></name><name><surname>Markovic</surname><given-names>I</given-names></name><name><surname>Telford</surname><given-names>WG</given-names></name><etal/></person-group><article-title>The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages</article-title><source>Virus Res</source><year>2007</year><volume>123</volume><fpage>178</fpage><lpage>189</lpage><?supplied-pmid 17030448?><pub-id pub-id-type="pmid">17030448</pub-id></element-citation></ref><ref id="CR172_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talarico</surname><given-names>LB</given-names></name><name><surname>Pujol</surname><given-names>CA</given-names></name><name><surname>Zibetti</surname><given-names>RG</given-names></name><etal/></person-group><article-title>The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell</article-title><source>Antiviral Res</source><year>2005</year><volume>66</volume><fpage>103</fpage><lpage>110</lpage><?supplied-pmid 15911027?><pub-id pub-id-type="pmid">15911027</pub-id></element-citation></ref><ref id="CR173_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tolo</surname><given-names>FM</given-names></name><name><surname>Rukunga</surname><given-names>GM</given-names></name><name><surname>Muli</surname><given-names>FW</given-names></name><etal/></person-group><article-title>Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus</article-title><source>J Ethnopharmacol</source><year>2006</year><volume>104</volume><fpage>92</fpage><lpage>99</lpage><?supplied-pmid 16198524?><pub-id pub-id-type="pmid">16198524</pub-id></element-citation></ref><ref id="CR03_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuske</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>K</given-names></name><name><surname>Kaushik</surname><given-names>N</given-names></name><etal/></person-group><article-title>The J-helix of Escherichia coli DNA polymerase I (Klenow fragment) regulates polymerase and 3&#x02019;- 5&#x02019;-exonuclease functions</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>23759</fpage><lpage>23768</lpage><pub-id pub-id-type="pmid">10818095</pub-id></element-citation></ref><ref id="CR174_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vela</surname><given-names>EM</given-names></name><name><surname>Bowick</surname><given-names>GC</given-names></name><name><surname>Herzog</surname><given-names>NK</given-names></name><etal/></person-group><article-title>Genistein treatment of cells inhibits arenavirus infection</article-title><source>Antiviral Res</source><year>2008</year><volume>77</volume><fpage>153</fpage><lpage>156</lpage><?supplied-pmid 17961732?><pub-id pub-id-type="pmid">17961732</pub-id></element-citation></ref><ref id="CR175_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vermani</surname><given-names>K</given-names></name><name><surname>Garg</surname><given-names>S</given-names></name></person-group><article-title>Herbal medicines for sexually transmitted diseases and AIDS</article-title><source>J Ethnopharmacol</source><year>2002</year><volume>80</volume><fpage>49</fpage><lpage>66</lpage><?supplied-pmid 11891087?><pub-id pub-id-type="pmid">11891087</pub-id></element-citation></ref><ref id="CR178_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>CX</given-names></name><name><surname>Zhang</surname><given-names>PH</given-names></name><name><surname>Luo</surname><given-names>JG</given-names></name><etal/></person-group><article-title>Homoflavonoid glucosides from Ophioglossum pedunculosum and their anti-HBV activity</article-title><source>J Nat Prod</source><year>2011</year><volume>74</volume><fpage>683</fpage><lpage>689</lpage><?supplied-pmid 21401115?><pub-id pub-id-type="pmid">21401115</pub-id></element-citation></ref><ref id="CR180_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>GF</given-names></name><name><surname>Shi</surname><given-names>LP</given-names></name><name><surname>Ren</surname><given-names>YD</given-names></name><etal/></person-group><article-title>Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro</article-title><source>Antiviral Res</source><year>2009</year><volume>83</volume><fpage>186</fpage><lpage>190</lpage><?supplied-pmid 19463857?><pub-id pub-id-type="pmid">19463857</pub-id></element-citation></ref><ref id="CR181_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><etal/></person-group><article-title>Lycium barbarum polysaccharide inhibits the infectivity of Newcastle disease virus to chicken embryo fibroblast</article-title><source>Int J Biol Macromol</source><year>2010</year><volume>46</volume><fpage>212</fpage><lpage>216</lpage><?supplied-pmid 19962398?><pub-id pub-id-type="pmid">19962398</pub-id></element-citation></ref><ref id="CR183_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webster</surname><given-names>D</given-names></name><name><surname>Taschereau</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>TD</given-names></name></person-group><article-title>Immunostimulant properties of <italic>Heracleum maximum</italic> Bartr</article-title><source>J Ethnopharmacol</source><year>2006</year><volume>106</volume><fpage>360</fpage><lpage>363</lpage><?supplied-pmid 16504434?><pub-id pub-id-type="pmid">16504434</pub-id></element-citation></ref><ref id="CR184_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>MP</given-names></name><name><surname>McCormick</surname><given-names>TG</given-names></name><name><surname>Nance</surname><given-names>CL</given-names></name><etal/></person-group><article-title>Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy</article-title><source>J Allergy Clin Immunol</source><year>2006</year><volume>118</volume><fpage>1369</fpage><lpage>1374</lpage><?supplied-pmid 17157668?><pub-id pub-id-type="pmid">17157668</pub-id></element-citation></ref><ref id="CR185_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>HR</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Hou</surname><given-names>W</given-names></name><etal/></person-group><article-title>The effect of emodin, an anthraquinone derivative extracted from the roots of Rheum tanguticum, against herpes simplex virus in vitro and in vivo</article-title><source>J Ethnopharmacol</source><year>2011</year><volume>133</volume><fpage>718</fpage><lpage>723</lpage><?supplied-pmid 21050882?><pub-id pub-id-type="pmid">21050882</pub-id></element-citation></ref><ref id="CR187_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>HX</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>SF</given-names></name><etal/></person-group><article-title>Isolation and characterization of an anti-HSV polysaccharide from <italic>Prunella vulgaris</italic></article-title><source>Antiviral Res</source><year>1999</year><volume>44</volume><fpage>43</fpage><lpage>54</lpage><?supplied-pmid 10588332?><pub-id pub-id-type="pmid">10588332</pub-id></element-citation></ref><ref id="CR188_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamai</surname><given-names>M</given-names></name><name><surname>Tsumura</surname><given-names>K</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antiviral activity of a hot water extract of black soybean against a human respiratory illness virus</article-title><source>Biosci Biotechnol Biochem</source><year>2003</year><volume>67</volume><fpage>1071</fpage><lpage>1079</lpage><?supplied-pmid 12834285?><pub-id pub-id-type="pmid">12834285</pub-id></element-citation></ref><ref id="CR189_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>CM</given-names></name><name><surname>Cheng</surname><given-names>HY</given-names></name><name><surname>Lin</surname><given-names>TC</given-names></name></person-group><article-title>Hippomanin A from acetone extract of <italic>Phyllanthus urinaria</italic> inhibited HSV-2 but not HSV-1 infection in vitro</article-title><source>Phytother Res</source><year>2007</year><volume>21</volume><fpage>1182</fpage><lpage>1186</lpage><?supplied-pmid 17661333?><pub-id pub-id-type="pmid">17661333</pub-id></element-citation></ref><ref id="CR191_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Yuan</surname><given-names>K</given-names></name><name><surname>Qu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>11334</fpage><lpage>11339</lpage><?supplied-pmid 15452254?><pub-id pub-id-type="pmid">15452254</pub-id></element-citation></ref><ref id="CR193_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yura</surname><given-names>Y</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name></person-group><article-title>Inhibition of herpes simplex virus replication by genistein, an inhibitor of protein-tyrosine kinase</article-title><source>Arch Virol</source><year>1993</year><volume>132</volume><fpage>451</fpage><lpage>461</lpage><?supplied-pmid 8397505?><pub-id pub-id-type="pmid">8397505</pub-id></element-citation></ref><ref id="CR194_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zakay-Rones</surname><given-names>Z</given-names></name><name><surname>Thom</surname><given-names>E</given-names></name><name><surname>Wollan</surname><given-names>T</given-names></name></person-group><article-title>Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections</article-title><source>J Int Med Res</source><year>2004</year><volume>32</volume><fpage>132</fpage><lpage>140</lpage><?supplied-pmid 15080016?><pub-id pub-id-type="pmid">15080016</pub-id></element-citation></ref><ref id="CR195_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Ye</surname><given-names>G</given-names></name><etal/></person-group><article-title>Antiviral effects of sophoridine against coxsackievirus B3 and its pharmacokinetics in rats</article-title><source>Life Sci</source><year>2006</year><volume>78</volume><fpage>1998</fpage><lpage>2005</lpage><?supplied-pmid 16309710?><pub-id pub-id-type="pmid">16309710</pub-id></element-citation></ref><ref id="CR197_3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>YL</given-names></name><name><surname>Cai</surname><given-names>GM</given-names></name><name><surname>Hong</surname><given-names>X</given-names></name><etal/></person-group><article-title>Anti-hepatitis B virus activities of triterpenoid saponin compound from <italic>Potentilla anserine</italic> L</article-title><source>Phytomedicine</source><year>2008</year><volume>15</volume><fpage>253</fpage><lpage>258</lpage><?supplied-pmid 18337074?><pub-id pub-id-type="pmid">18337074</pub-id></element-citation></ref></ref-list></back></article>